Frequencies for first 10,000 rows of pt variable in reac2005q3 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABASIA | 10 0.10 0.10 ABDOMINAL ADHESIONS | 1 0.01 0.11 ABDOMINAL DISCOMFORT | 3 0.03 0.14 ABDOMINAL DISTENSION | 14 0.14 0.28 ABDOMINAL HAEMATOMA | 2 0.02 0.30 ABDOMINAL NEOPLASM | 1 0.01 0.31 ABDOMINAL PAIN | 48 0.48 0.79 ABDOMINAL PAIN LOWER | 1 0.01 0.80 ABDOMINAL PAIN UPPER | 29 0.29 1.09 ABDOMINAL RIGIDITY | 1 0.01 1.10 ABDOMINAL SEPSIS | 1 0.01 1.11 ABDOMINAL SYMPTOM | 1 0.01 1.12 ABDOMINAL TENDERNESS | 3 0.03 1.15 ABNORMAL BEHAVIOUR | 12 0.12 1.27 ABNORMAL DREAMS | 1 0.01 1.28 ABNORMAL LABOUR | 1 0.01 1.29 ABNORMAL SENSATION IN EYE | 2 0.02 1.31 ABORTION INDUCED | 5 0.05 1.36 ABORTION SPONTANEOUS | 8 0.08 1.44 ABSCESS | 4 0.04 1.48 ABSCESS INTESTINAL | 1 0.01 1.49 ABSCESS JAW | 1 0.01 1.50 ACCELERATED IDIOVENTRICULAR RHYTHM | 1 0.01 1.51 ACCIDENT AT HOME | 1 0.01 1.52 ACCIDENTAL DEATH | 1 0.01 1.53 ACCIDENTAL EXPOSURE | 2 0.02 1.55 ACCIDENTAL OVERDOSE | 7 0.07 1.62 ACCOMMODATION DISORDER | 1 0.01 1.63 ACID FAST BACILLI INFECTION | 1 0.01 1.64 ACINETOBACTER INFECTION | 1 0.01 1.65 ACNE | 4 0.04 1.69 ACQUIRED IMMUNODEFICIENCY SYNDROME | 1 0.01 1.70 ACTINOMYCOSIS | 1 0.01 1.71 ACTIVATED PARTIAL THROMBOPLASTIN TIME.. | 4 0.04 1.75 ACTIVITIES OF DAILY LIVING IMPAIRED | 4 0.04 1.79 ACUTE CORONARY SYNDROME | 2 0.02 1.81 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS | 2 0.02 1.83 ACUTE GENERALISED EXANTHEMATOUS PUSTU.. | 2 0.02 1.85 ACUTE LEUKAEMIA | 1 0.01 1.86 ACUTE MYELOID LEUKAEMIA | 2 0.02 1.88 ACUTE MYELOID LEUKAEMIA RECURRENT | 1 0.01 1.89 ACUTE MYOCARDIAL INFARCTION | 11 0.11 2.00 ACUTE PRERENAL FAILURE | 1 0.01 2.01 ACUTE PSYCHOSIS | 1 0.01 2.02 ACUTE PULMONARY OEDEMA | 3 0.03 2.05 ACUTE RESPIRATORY DISTRESS SYNDROME | 3 0.03 2.08 ACUTE RESPIRATORY FAILURE | 1 0.01 2.09 ACUTE SINUSITIS | 3 0.03 2.12 ACUTE TONSILLITIS | 1 0.01 2.13 ADAMS-STOKES SYNDROME | 1 0.01 2.14 ADENOIDAL HYPERTROPHY | 1 0.01 2.15 ADENOMYOSIS | 1 0.01 2.16 ADENOVIRAL HAEMORRHAGIC CYSTITIS | 1 0.01 2.17 ADNEXA UTERI MASS | 1 0.01 2.18 ADRENAL MASS | 1 0.01 2.19 ADRENAL NEOPLASM | 1 0.01 2.20 ADRENOCORTICAL INSUFFICIENCY ACUTE | 1 0.01 2.21 ADRENOCORTICAL INSUFFICIENCY CHRONIC | 1 0.01 2.22 ADVERSE DRUG REACTION | 1 0.01 2.23 ADVERSE EVENT | 6 0.06 2.29 AGEUSIA | 4 0.04 2.33 AGGRESSION | 20 0.20 2.53 AGITATION | 18 0.18 2.71 AGITATION NEONATAL | 2 0.02 2.73 AGORAPHOBIA | 1 0.01 2.74 AGRANULOCYTOSIS | 5 0.05 2.79 AIRWAY COMPLICATION OF ANAESTHESIA | 1 0.01 2.80 ALANINE AMINOTRANSFERASE INCREASED | 39 0.39 3.19 ALBUMIN URINE PRESENT | 1 0.01 3.20 ALCOHOL INTERACTION | 1 0.01 3.21 ALCOHOL POISONING | 2 0.02 3.23 ALCOHOL USE | 7 0.07 3.30 ALDOLASE INCREASED | 1 0.01 3.31 ALLERGIC GRANULOMATOUS ANGIITIS | 4 0.04 3.35 ALLERGIC SINUSITIS | 1 0.01 3.36 ALOPECIA | 14 0.14 3.50 ALPHA 1 FOETOPROTEIN INCREASED | 1 0.01 3.51 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECT.. | 1 0.01 3.52 ALVEOLAR PROTEINOSIS | 1 0.01 3.53 AMBLYOPIA | 2 0.02 3.55 AMENORRHOEA | 2 0.02 3.57 AMMONIA INCREASED | 1 0.01 3.58 AMNESIA | 13 0.13 3.71 AMNIOTIC FLUID VOLUME DECREASED | 1 0.01 3.72 AMOEBIC DYSENTERY | 1 0.01 3.73 AMPHETAMINES | 1 0.01 3.74 AMYLOIDOSIS | 1 0.01 3.75 AMYOTROPHIC LATERAL SCLEROSIS | 1 0.01 3.76 AMYOTROPHY | 1 0.01 3.77 ANAEMIA | 48 0.48 4.25 ANAEMIA MACROCYTIC | 4 0.04 4.29 ANAEMIA OF CHRONIC DISEASE | 1 0.01 4.30 ANAESTHETIC COMPLICATION | 1 0.01 4.31 ANAL CANCER | 1 0.01 4.32 ANAL DISCOMFORT | 1 0.01 4.33 ANAL FISSURE | 1 0.01 4.34 ANAPHYLACTIC REACTION | 7 0.07 4.41 ANAPHYLACTIC SHOCK | 12 0.12 4.53 ANAPHYLACTOID REACTION | 1 0.01 4.54 ANENCEPHALY | 2 0.02 4.56 ANEURYSM | 2 0.02 4.58 ANEURYSM RUPTURED | 1 0.01 4.59 ANGER | 9 0.09 4.68 ANGINA PECTORIS | 23 0.23 4.91 ANGINA UNSTABLE | 6 0.06 4.97 ANGIODYSPLASIA | 1 0.01 4.98 ANGIONEUROTIC OEDEMA | 11 0.11 5.09 ANGLE CLOSURE GLAUCOMA | 1 0.01 5.10 ANHEDONIA | 12 0.12 5.22 ANION GAP DECREASED | 1 0.01 5.23 ANION GAP INCREASED | 1 0.01 5.24 ANORECTAL DISORDER | 1 0.01 5.25 ANOREXIA | 32 0.32 5.57 ANORGASMIA | 2 0.02 5.59 ANOSMIA | 4 0.04 5.63 ANTI-HBS ANTIBODY POSITIVE | 1 0.01 5.64 ANTI-PLATELET ANTIBODY | 1 0.01 5.65 ANTI-PLATELET ANTIBODY POSITIVE | 1 0.01 5.66 ANTIBODY TEST ABNORMAL | 1 0.01 5.67 ANTIBODY TEST POSITIVE | 3 0.03 5.70 ANTICHOLINERGIC SYNDROME | 1 0.01 5.71 ANTICONVULSANT DRUG LEVEL ABOVE THERA.. | 1 0.01 5.72 ANTICONVULSANT DRUG LEVEL BELOW THERA.. | 1 0.01 5.73 ANTICONVULSANT DRUG LEVEL INCREASED | 1 0.01 5.74 ANTICONVULSANT TOXICITY | 1 0.01 5.75 ANTIDEPRESSANT DRUG LEVEL DECREASED | 1 0.01 5.76 ANTINUCLEAR ANTIBODY POSITIVE | 5 0.05 5.81 ANTIPHOSPHOLIPID SYNDROME | 2 0.02 5.83 ANURIA | 9 0.09 5.92 ANXIETY | 50 0.50 6.42 ANXIETY DISORDER | 1 0.01 6.43 AORTIC ANEURYSM | 2 0.02 6.45 AORTIC ATHEROSCLEROSIS | 1 0.01 6.46 AORTIC CALCIFICATION | 1 0.01 6.47 AORTIC DISSECTION | 1 0.01 6.48 AORTIC SURGERY | 1 0.01 6.49 AORTIC VALVE INCOMPETENCE | 4 0.04 6.53 AORTIC VALVE SCLEROSIS | 2 0.02 6.55 AORTIC VALVE STENOSIS | 2 0.02 6.57 APATHY | 3 0.03 6.60 APGAR SCORE LOW | 1 0.01 6.61 APHASIA | 8 0.08 6.69 APHONIA | 1 0.01 6.70 APHTHOUS STOMATITIS | 1 0.01 6.71 APLASIA PURE RED CELL | 2 0.02 6.73 APLASTIC ANAEMIA | 2 0.02 6.75 APNOEA | 2 0.02 6.77 APPENDICECTOMY | 1 0.01 6.78 APPENDICITIS | 4 0.04 6.82 APPENDIX DISORDER | 2 0.02 6.84 APPETITE DISORDER | 1 0.01 6.85 APPLICATION SITE REACTION | 1 0.01 6.86 APPLICATION SITE URTICARIA | 1 0.01 6.87 APRAXIA | 1 0.01 6.88 ARACHNOIDITIS | 1 0.01 6.89 ARRHYTHMIA | 8 0.08 6.97 ARRHYTHMIA SUPRAVENTRICULAR | 1 0.01 6.98 ARTERIAL CATHETERISATION ABNORMAL | 1 0.01 6.99 ARTERIAL OCCLUSIVE DISEASE | 2 0.02 7.01 ARTERIAL THROMBOSIS | 1 0.01 7.02 ARTERIAL THROMBOSIS LIMB | 1 0.01 7.03 ARTERIOGRAM CORONARY ABNORMAL | 1 0.01 7.04 ARTERIOSCLEROSIS | 1 0.01 7.05 ARTERIOSPASM CORONARY | 2 0.02 7.07 ARTERITIS | 1 0.01 7.08 ARTHRALGIA | 27 0.27 7.35 ARTHRITIS | 3 0.03 7.38 ARTHRITIS BACTERIAL | 1 0.01 7.39 ARTHRITIS ENTEROPATHIC | 1 0.01 7.40 ARTHRITIS INFECTIVE | 2 0.02 7.42 ARTHROPATHY | 4 0.04 7.46 ARTHROSCOPY | 1 0.01 7.47 ASCITES | 12 0.12 7.59 ASCITES INFECTION | 1 0.01 7.60 ASEPTIC NECROSIS BONE | 30 0.30 7.90 ASPARTATE AMINOTRANSFERASE ABNORMAL | 1 0.01 7.91 ASPARTATE AMINOTRANSFERASE DECREASED | 1 0.01 7.92 ASPARTATE AMINOTRANSFERASE INCREASED | 34 0.34 8.26 ASPERGILLOSIS | 2 0.02 8.28 ASPIRATION | 3 0.03 8.31 ASTHENIA | 70 0.70 9.01 ASTHENOPIA | 1 0.01 9.02 ASTHMA | 9 0.09 9.11 ASTIGMATISM | 1 0.01 9.12 ATELECTASIS | 7 0.07 9.19 ATHEROSCLEROSIS | 7 0.07 9.26 ATONIC SEIZURES | 1 0.01 9.27 ATRIAL FIBRILLATION | 21 0.21 9.48 ATRIAL FLUTTER | 2 0.02 9.50 ATRIAL SEPTAL DEFECT | 1 0.01 9.51 ATRIAL THROMBOSIS | 2 0.02 9.53 ATRIOVENTRICULAR BLOCK | 2 0.02 9.55 ATRIOVENTRICULAR BLOCK COMPLETE | 1 0.01 9.56 ATRIOVENTRICULAR BLOCK FIRST DEGREE | 2 0.02 9.58 ATROPHY | 2 0.02 9.60 ATTENTION DEFICIT/HYPERACTIVITY DISOR.. | 2 0.02 9.62 AURA | 1 0.01 9.63 AURICULAR SWELLING | 1 0.01 9.64 AUTOANTIBODY POSITIVE | 1 0.01 9.65 AUTOIMMUNE DISORDER | 3 0.03 9.68 AUTOIMMUNE HEPATITIS | 3 0.03 9.71 AUTONOMIC NERVOUS SYSTEM IMBALANCE | 1 0.01 9.72 AUTONOMIC NEUROPATHY | 2 0.02 9.74 AZOTAEMIA | 2 0.02 9.76 BACILLUS INFECTION | 1 0.01 9.77 BACK DISORDER | 4 0.04 9.81 BACK INJURY | 2 0.02 9.83 BACK PAIN | 38 0.38 10.21 BACTERAEMIA | 3 0.03 10.24 BACTERIAL INFECTION | 7 0.07 10.31 BALANCE DISORDER | 17 0.17 10.48 BARBITURATES | 1 0.01 10.49 BASAL CELL CARCINOMA | 1 0.01 10.50 BASEDOW'S DISEASE | 1 0.01 10.51 BASILAR MIGRAINE | 1 0.01 10.52 BEDRIDDEN | 2 0.02 10.54 BENIGN INTRACRANIAL HYPERTENSION | 2 0.02 10.56 BENIGN NEOPLASM OF THYROID GLAND | 1 0.01 10.57 BENIGN PROSTATIC HYPERPLASIA | 3 0.03 10.60 BETA 2 MICROGLOBULIN INCREASED | 1 0.01 10.61 BILE DUCT OBSTRUCTION | 1 0.01 10.62 BILE DUCT STONE | 1 0.01 10.63 BILIARY COLIC | 1 0.01 10.64 BILIARY ISCHAEMIA | 1 0.01 10.65 BILIRUBIN CONJUGATED INCREASED | 2 0.02 10.67 BINOCULAR EYE MOVEMENT DISORDER | 1 0.01 10.68 BIOPSY LIVER ABNORMAL | 1 0.01 10.69 BIOPSY THYROID GLAND | 1 0.01 10.70 BIPOLAR DISORDER | 3 0.03 10.73 BIPOLAR I DISORDER | 2 0.02 10.75 BLADDER CATHETERISATION | 2 0.02 10.77 BLADDER DISORDER | 2 0.02 10.79 BLADDER DISTENSION | 1 0.01 10.80 BLADDER PAIN | 2 0.02 10.82 BLADDER PROLAPSE | 1 0.01 10.83 BLADDER REPAIR | 1 0.01 10.84 BLADDER STENOSIS | 1 0.01 10.85 BLASTOCYSTIS INFECTION | 1 0.01 10.86 BLEEDING TIME PROLONGED | 1 0.01 10.87 BLEPHARITIS | 2 0.02 10.89 BLEPHAROSPASM | 1 0.01 10.90 BLINDNESS | 4 0.04 10.94 BLINDNESS TRANSIENT | 2 0.02 10.96 BLINDNESS UNILATERAL | 3 0.03 10.99 BLISTER | 9 0.09 11.08 BLOOD ALBUMIN DECREASED | 6 0.06 11.14 BLOOD ALBUMIN INCREASED | 1 0.01 11.15 BLOOD ALKALINE PHOSPHATASE DECREASED | 1 0.01 11.16 BLOOD ALKALINE PHOSPHATASE INCREASED | 20 0.20 11.36 BLOOD AMYLASE INCREASED | 3 0.03 11.39 BLOOD ANTIDIURETIC HORMONE INCREASED | 1 0.01 11.40 BLOOD BICARBONATE DECREASED | 2 0.02 11.42 BLOOD BICARBONATE INCREASED | 1 0.01 11.43 BLOOD BILIRUBIN INCREASED | 18 0.18 11.61 BLOOD BILIRUBIN UNCONJUGATED INCREASED | 1 0.01 11.62 BLOOD CAFFEINE | 1 0.01 11.63 BLOOD CALCIUM INCREASED | 2 0.02 11.65 BLOOD CHLORIDE DECREASED | 2 0.02 11.67 BLOOD CHOLESTEROL DECREASED | 1 0.01 11.68 BLOOD CHOLESTEROL INCREASED | 17 0.17 11.85 BLOOD CORTICOTROPHIN DECREASED | 1 0.01 11.86 BLOOD CREATINE ABNORMAL | 1 0.01 11.87 BLOOD CREATINE INCREASED | 1 0.01 11.88 BLOOD CREATINE PHOSPHOKINASE INCREASED | 31 0.31 12.19 BLOOD CREATINE PHOSPHOKINASE MM | 1 0.01 12.20 BLOOD CREATININE ABNORMAL | 3 0.03 12.23 BLOOD CREATININE INCREASED | 28 0.28 12.51 BLOOD CULTURE POSITIVE | 2 0.02 12.53 BLOOD DISORDER | 3 0.03 12.56 BLOOD ELECTROLYTES ABNORMAL | 2 0.02 12.58 BLOOD GASES ABNORMAL | 1 0.01 12.59 BLOOD GLUCOSE DECREASED | 3 0.03 12.62 BLOOD GLUCOSE FLUCTUATION | 2 0.02 12.64 BLOOD GLUCOSE INCREASED | 20 0.20 12.84 BLOOD HOMOCYSTEINE INCREASED | 1 0.01 12.85 BLOOD HUMAN CHORIONIC GONADOTROPIN IN.. | 2 0.02 12.87 BLOOD IMMUNOGLOBULIN E INCREASED | 1 0.01 12.88 BLOOD IMMUNOGLOBULIN G INCREASED | 1 0.01 12.89 BLOOD IRON DECREASED | 1 0.01 12.90 BLOOD IRON INCREASED | 1 0.01 12.91 BLOOD KETONE BODY DECREASED | 1 0.01 12.92 BLOOD KETONE BODY INCREASED | 5 0.05 12.97 BLOOD KETONE BODY PRESENT | 1 0.01 12.98 BLOOD LACTATE DEHYDROGENASE INCREASED | 13 0.13 13.11 BLOOD LACTIC ACID INCREASED | 14 0.14 13.25 BLOOD MAGNESIUM DECREASED | 2 0.02 13.27 BLOOD OSMOLARITY DECREASED | 2 0.02 13.29 BLOOD PARATHYROID HORMONE INCREASED | 1 0.01 13.30 BLOOD PHOSPHORUS DECREASED | 1 0.01 13.31 BLOOD PHOSPHORUS INCREASED | 1 0.01 13.32 BLOOD POTASSIUM DECREASED | 4 0.04 13.36 BLOOD POTASSIUM INCREASED | 9 0.09 13.45 BLOOD PRESSURE ABNORMAL | 2 0.02 13.47 BLOOD PRESSURE DECREASED | 16 0.16 13.63 BLOOD PRESSURE DIASTOLIC DECREASED | 1 0.01 13.64 BLOOD PRESSURE FLUCTUATION | 2 0.02 13.66 BLOOD PRESSURE INCREASED | 33 0.33 13.99 BLOOD PRESSURE SYSTOLIC DECREASED | 1 0.01 14.00 BLOOD PRESSURE SYSTOLIC INCREASED | 5 0.05 14.05 BLOOD PYRUVIC ACID DECREASED | 2 0.02 14.07 BLOOD PYRUVIC ACID INCREASED | 2 0.02 14.09 BLOOD SODIUM DECREASED | 4 0.04 14.13 BLOOD SODIUM INCREASED | 1 0.01 14.14 BLOOD STEM CELL TRANSPLANT FAILURE | 1 0.01 14.15 BLOOD THYROID STIMULATING HORMONE ABN.. | 1 0.01 14.16 BLOOD THYROID STIMULATING HORMONE INC.. | 2 0.02 14.18 BLOOD TRIGLYCERIDES DECREASED | 1 0.01 14.19 BLOOD TRIGLYCERIDES INCREASED | 5 0.05 14.24 BLOOD UREA ABNORMAL | 1 0.01 14.25 BLOOD UREA INCREASED | 10 0.10 14.35 BLOOD URIC ACID INCREASED | 2 0.02 14.37 BLOODY DISCHARGE | 1 0.01 14.38 BODY HEIGHT DECREASED | 4 0.04 14.42 BODY TEMPERATURE DECREASED | 4 0.04 14.46 BODY TEMPERATURE INCREASED | 7 0.07 14.53 BONE DEBRIDEMENT | 2 0.02 14.55 BONE DENSITY DECREASED | 2 0.02 14.57 BONE DENSITY INCREASED | 3 0.03 14.60 BONE DISORDER | 8 0.08 14.68 BONE EROSION | 2 0.02 14.70 BONE INFECTION | 1 0.01 14.71 BONE MARROW DEPRESSION | 6 0.06 14.77 BONE MARROW TRANSPLANT | 1 0.01 14.78 BONE OPERATION | 1 0.01 14.79 BONE PAIN | 6 0.06 14.85 BONE SCAN ABNORMAL | 1 0.01 14.86 BONE SWELLING | 1 0.01 14.87 BORDERLINE PERSONALITY DISORDER | 1 0.01 14.88 BOVINE TUBERCULOSIS | 1 0.01 14.89 BOWEL SOUNDS ABNORMAL | 5 0.05 14.94 BOWEN'S DISEASE | 1 0.01 14.95 BRADYARRHYTHMIA | 1 0.01 14.96 BRADYCARDIA | 16 0.16 15.12 BRADYKINESIA | 1 0.01 15.13 BRADYPHRENIA | 1 0.01 15.14 BRAIN DAMAGE | 1 0.01 15.15 BRAIN DEATH | 3 0.03 15.18 BRAIN HERNIATION | 1 0.01 15.19 BRAIN HYPOXIA | 1 0.01 15.20 BRAIN NATRIURETIC PEPTIDE INCREASED | 1 0.01 15.21 BRAIN OEDEMA | 6 0.06 15.27 BRAIN STEM INFARCTION | 1 0.01 15.28 BRAIN STEM SYNDROME | 1 0.01 15.29 BREAST ABSCESS | 2 0.02 15.31 BREAST CANCER | 2 0.02 15.33 BREAST CANCER FEMALE | 11 0.11 15.44 BREAST CANCER METASTATIC | 3 0.03 15.47 BREAST MASS | 2 0.02 15.49 BREAST OEDEMA | 1 0.01 15.50 BREAST PAIN | 2 0.02 15.52 BREATH HOLDING | 1 0.01 15.53 BREATH ODOUR | 1 0.01 15.54 BRONCHIAL CARCINOMA | 1 0.01 15.55 BRONCHIECTASIS | 1 0.01 15.56 BRONCHIOLITIS | 1 0.01 15.57 BRONCHITIS | 5 0.05 15.62 BRONCHITIS ACUTE | 1 0.01 15.63 BRONCHOPLEURAL FISTULA | 1 0.01 15.64 BRONCHOPNEUMONIA | 5 0.05 15.69 BRONCHOPNEUMOPATHY | 2 0.02 15.71 BRONCHOPULMONARY ASPERGILLOSIS | 1 0.01 15.72 BRONCHOSPASM | 6 0.06 15.78 BUDD-CHIARI SYNDROME | 1 0.01 15.79 BUNDLE BRANCH BLOCK | 1 0.01 15.80 BUNDLE BRANCH BLOCK LEFT | 3 0.03 15.83 BURNING SENSATION | 5 0.05 15.88 BURNS SECOND DEGREE | 1 0.01 15.89 BURSITIS | 1 0.01 15.90 BUTTOCK PAIN | 1 0.01 15.91 C-REACTIVE PROTEIN INCREASED | 14 0.14 16.05 CACHEXIA | 2 0.02 16.07 CAECITIS | 2 0.02 16.09 CAESAREAN SECTION | 10 0.10 16.19 CALCIUM IONISED DECREASED | 1 0.01 16.20 CALCULUS BLADDER | 1 0.01 16.21 CAMPYLOBACTER INTESTINAL INFECTION | 1 0.01 16.22 CANDIDIASIS | 7 0.07 16.29 CAPILLARY DISORDER | 1 0.01 16.30 CAPILLARY LEAK SYNDROME | 1 0.01 16.31 CARBON MONOXIDE POISONING | 1 0.01 16.32 CARCINOID TUMOUR OF THE PANCREAS | 1 0.01 16.33 CARDIAC ANEURYSM | 2 0.02 16.35 CARDIAC ARREST | 22 0.22 16.57 CARDIAC DISORDER | 23 0.23 16.80 CARDIAC ENZYMES INCREASED | 2 0.02 16.82 CARDIAC FAILURE | 20 0.20 17.02 CARDIAC FAILURE CONGESTIVE | 27 0.27 17.29 CARDIAC INFECTION | 1 0.01 17.30 CARDIAC MURMUR | 12 0.12 17.42 CARDIAC OPERATION | 1 0.01 17.43 CARDIAC PACEMAKER INSERTION | 2 0.02 17.45 CARDIAC PERFORATION | 1 0.01 17.46 CARDIAC PROCEDURE COMPLICATION | 1 0.01 17.47 CARDIAC STRESS TEST ABNORMAL | 1 0.01 17.48 CARDIAC TAMPONADE | 5 0.05 17.53 CARDIAC VALVE DISEASE | 3 0.03 17.56 CARDIO-RESPIRATORY ARREST | 13 0.13 17.69 CARDIOACTIVE DRUG LEVEL INCREASED | 1 0.01 17.70 CARDIOGENIC SHOCK | 6 0.06 17.76 CARDIOMEGALY | 5 0.05 17.81 CARDIOMYOPATHY | 4 0.04 17.85 CARDIOVASCULAR DISORDER | 6 0.06 17.91 CARNITINE DECREASED | 1 0.01 17.92 CAROTID ARTERY DISEASE | 1 0.01 17.93 CAROTID ARTERY OCCLUSION | 1 0.01 17.94 CAROTID ARTERY STENOSIS | 4 0.04 17.98 CAROTID BRUIT | 1 0.01 17.99 CARPAL TUNNEL DECOMPRESSION | 1 0.01 18.00 CARPAL TUNNEL SYNDROME | 2 0.02 18.02 CATAPLEXY | 1 0.01 18.03 CATARACT | 7 0.07 18.10 CATARACT OPERATION | 1 0.01 18.11 CATATONIA | 1 0.01 18.12 CATHETER PLACEMENT | 1 0.01 18.13 CATHETER RELATED COMPLICATION | 1 0.01 18.14 CATHETER RELATED INFECTION | 3 0.03 18.17 CATHETER REMOVAL | 1 0.01 18.18 CATHETER SEPSIS | 1 0.01 18.19 CATHETER SITE HAEMATOMA | 1 0.01 18.20 CATHETER SITE INFECTION | 2 0.02 18.22 CATHETERISATION CARDIAC | 1 0.01 18.23 CAUDA EQUINA SYNDROME | 1 0.01 18.24 CELLULITIS | 9 0.09 18.33 CENTRAL LINE INFECTION | 2 0.02 18.35 CENTRAL NERVOUS SYSTEM LESION | 1 0.01 18.36 CENTRAL VENOUS CATHETERISATION | 2 0.02 18.38 CEREBELLAR ATROPHY | 1 0.01 18.39 CEREBELLAR SYNDROME | 1 0.01 18.40 CEREBRAL ARTERY OCCLUSION | 1 0.01 18.41 CEREBRAL ATHEROSCLEROSIS | 1 0.01 18.42 CEREBRAL ATROPHY | 1 0.01 18.43 CEREBRAL DISORDER | 1 0.01 18.44 CEREBRAL HAEMATOMA | 1 0.01 18.45 CEREBRAL HAEMORRHAGE | 6 0.06 18.51 CEREBRAL INFARCTION | 14 0.14 18.65 CEREBRAL ISCHAEMIA | 4 0.04 18.69 CEREBRAL PALSY | 1 0.01 18.70 CEREBRAL THROMBOSIS | 1 0.01 18.71 CEREBRAL VENTRICLE DILATATION | 2 0.02 18.73 CEREBROSPINAL FLUID LEAKAGE | 1 0.01 18.74 CEREBROVASCULAR ACCIDENT | 77 0.77 19.51 CEREBROVASCULAR DISORDER | 2 0.02 19.53 CEREBROVASCULAR INSUFFICIENCY | 1 0.01 19.54 CERUMEN IMPACTION | 1 0.01 19.55 CERVICAL GLAND TUBERCULOSIS | 1 0.01 19.56 CERVICAL SPINAL STENOSIS | 1 0.01 19.57 CERVICAL VERTEBRAL FRACTURE | 1 0.01 19.58 CERVICITIS | 1 0.01 19.59 CERVICOBRACHIAL SYNDROME | 2 0.02 19.61 CERVIX CARCINOMA | 1 0.01 19.62 CHEILITIS | 3 0.03 19.65 CHEMICAL POISONING | 1 0.01 19.66 CHEST DISCOMFORT | 7 0.07 19.73 CHEST PAIN | 52 0.52 20.25 CHEST WALL PAIN | 2 0.02 20.27 CHEYNE-STOKES RESPIRATION | 1 0.01 20.28 CHILLS | 21 0.21 20.49 CHOKING | 4 0.04 20.53 CHOLANGITIS | 2 0.02 20.55 CHOLECYSTECTOMY | 2 0.02 20.57 CHOLECYSTITIS | 1 0.01 20.58 CHOLECYSTITIS CHRONIC | 1 0.01 20.59 CHOLECYSTITIS INFECTIVE | 1 0.01 20.60 CHOLELITHIASIS | 4 0.04 20.64 CHOLELITHIASIS OBSTRUCTIVE | 1 0.01 20.65 CHOLESTASIS | 11 0.11 20.76 CHOLESTEATOMA | 1 0.01 20.77 CHOREA | 1 0.01 20.78 CHOREOATHETOSIS | 1 0.01 20.79 CHOROIDAL RUPTURE | 1 0.01 20.80 CHROMATURIA | 8 0.08 20.88 CHRONIC FATIGUE SYNDROME | 2 0.02 20.90 CHRONIC LYMPHOCYTIC LEUKAEMIA | 1 0.01 20.91 CHRONIC MYELOID LEUKAEMIA | 1 0.01 20.92 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 13 0.13 21.05 CHRONIC SINUSITIS | 1 0.01 21.06 CHYLOTHORAX | 1 0.01 21.07 CIRCULATORY COLLAPSE | 6 0.06 21.13 CIRCUMCISION | 1 0.01 21.14 CLONUS | 1 0.01 21.15 CLOSTRIDIAL INFECTION | 2 0.02 21.17 CLOSTRIDIUM COLITIS | 7 0.07 21.24 CLOSTRIDIUM DIFFICILE TOXIN TEST POSI.. | 1 0.01 21.25 CLUMSINESS | 1 0.01 21.26 COAGULOPATHY | 2 0.02 21.28 COARCTATION OF THE AORTA | 2 0.02 21.30 COGNITIVE DISORDER | 2 0.02 21.32 COLD EXPOSURE INJURY | 1 0.01 21.33 COLD SWEAT | 6 0.06 21.39 COLECTOMY TOTAL | 1 0.01 21.40 COLITIS | 21 0.21 21.61 COLITIS ISCHAEMIC | 3 0.03 21.64 COLITIS ULCERATIVE | 15 0.15 21.79 COLLAPSE OF LUNG | 2 0.02 21.81 COLON ADENOMA | 1 0.01 21.82 COLON CANCER | 2 0.02 21.84 COLON CANCER METASTATIC | 1 0.01 21.85 COLON OPERATION | 1 0.01 21.86 COLONIC HAEMORRHAGE | 1 0.01 21.87 COLONIC POLYP | 2 0.02 21.89 COLONIC STENOSIS | 1 0.01 21.90 COMA | 8 0.08 21.98 COMMUNICATION DISORDER | 3 0.03 22.01 COMPARTMENT SYNDROME | 1 0.01 22.02 COMPLETED SUICIDE | 26 0.26 22.28 COMPLEX PARTIAL SEIZURES | 1 0.01 22.29 COMPLEX REGIONAL PAIN SYNDROME | 1 0.01 22.30 COMPLICATION OF DEVICE INSERTION | 1 0.01 22.31 COMPLICATIONS OF BONE MARROW TRANSPLANT | 2 0.02 22.33 COMPLICATIONS OF TRANSPLANTED KIDNEY | 2 0.02 22.35 COMPUTERISED TOMOGRAM ABNORMAL | 1 0.01 22.36 CONCOMITANT DISEASE PROGRESSION | 2 0.02 22.38 CONDITION AGGRAVATED | 42 0.42 22.80 CONDUCTION DISORDER | 2 0.02 22.82 CONFUSIONAL STATE | 42 0.42 23.24 CONGENITAL GENITOURINARY ABNORMALITY | 1 0.01 23.25 CONJUNCTIVAL HYPERAEMIA | 3 0.03 23.28 CONJUNCTIVAL OEDEMA | 1 0.01 23.29 CONJUNCTIVITIS | 4 0.04 23.33 CONJUNCTIVITIS BACTERIAL | 1 0.01 23.34 CONSTIPATION | 30 0.30 23.64 CONTRAINDICATION TO MEDICAL TREATMENT | 1 0.01 23.65 CONTRAST MEDIA REACTION | 1 0.01 23.66 CONTUSION | 13 0.13 23.79 CONVERSION DISORDER | 1 0.01 23.80 CONVULSION | 50 0.50 24.30 COOMBS DIRECT TEST POSITIVE | 1 0.01 24.31 COORDINATION ABNORMAL | 12 0.12 24.43 CORNEAL DISORDER | 1 0.01 24.44 CORONARY ARTERY ATHEROSCLEROSIS | 3 0.03 24.47 CORONARY ARTERY DISEASE | 26 0.26 24.73 CORONARY ARTERY DISSECTION | 1 0.01 24.74 CORONARY ARTERY INSUFFICIENCY | 1 0.01 24.75 CORONARY ARTERY OCCLUSION | 8 0.08 24.83 CORONARY ARTERY PERFORATION | 1 0.01 24.84 CORONARY ARTERY RESTENOSIS | 1 0.01 24.85 CORONARY ARTERY STENOSIS | 4 0.04 24.89 CORONARY ARTERY THROMBOSIS | 1 0.01 24.90 COUGH | 27 0.27 25.17 CRANIAL NEUROPATHY | 1 0.01 25.18 CREATININE RENAL CLEARANCE DECREASED | 1 0.01 25.19 CREST SYNDROME | 1 0.01 25.20 CROHN'S DISEASE | 14 0.14 25.34 CRYING | 6 0.06 25.40 CRYPTOGENIC ORGANIZING PNEUMONIA | 2 0.02 25.42 CRYPTORCHISM | 1 0.01 25.43 CSF PRESSURE INCREASED | 1 0.01 25.44 CSF PROTEIN INCREASED | 1 0.01 25.45 CULTURE URINE POSITIVE | 2 0.02 25.47 CULTURE WOUND POSITIVE | 2 0.02 25.49 CUSHING'S SYNDROME | 3 0.03 25.52 CUTANEOUS LUPUS ERYTHEMATOSUS | 1 0.01 25.53 CYANOSIS | 11 0.11 25.64 CYST | 2 0.02 25.66 CYSTITIS | 5 0.05 25.71 CYSTOCELE | 2 0.02 25.73 CYTOKINE STORM | 1 0.01 25.74 CYTOLYTIC HEPATITIS | 4 0.04 25.78 CYTOMEGALOVIRUS ANTIBODY POSITIVE | 1 0.01 25.79 CYTOMEGALOVIRUS CHORIORETINITIS | 1 0.01 25.80 CYTOMEGALOVIRUS ENTEROCOLITIS | 1 0.01 25.81 CYTOMEGALOVIRUS INFECTION | 3 0.03 25.84 DAYDREAMING | 1 0.01 25.85 DEAFNESS | 6 0.06 25.91 DEAFNESS BILATERAL | 2 0.02 25.93 DEAFNESS UNILATERAL | 2 0.02 25.95 DEATH | 54 0.54 26.49 DEATH NEONATAL | 2 0.02 26.51 DECREASED APPETITE | 10 0.10 26.61 DECREASED IMMUNE RESPONSIVENESS | 1 0.01 26.62 DEEP VEIN THROMBOSIS | 17 0.17 26.79 DEHYDRATION | 48 0.48 27.27 DELAYED EFFECTS OF RADIATION | 1 0.01 27.28 DELAYED ENGRAFTMENT | 1 0.01 27.29 DELIRIUM | 9 0.09 27.38 DELUSION | 2 0.02 27.40 DELUSIONAL DISORDER, PERSECUTORY TYPE | 1 0.01 27.41 DEMENTIA | 2 0.02 27.43 DEMENTIA ALZHEIMER'S TYPE | 1 0.01 27.44 DEMYELINATION | 2 0.02 27.46 DENTAL CARIES | 2 0.02 27.48 DENTAL TREATMENT | 2 0.02 27.50 DEPRESSED LEVEL OF CONSCIOUSNESS | 33 0.33 27.83 DEPRESSED MOOD | 3 0.03 27.86 DEPRESSION | 65 0.65 28.51 DEPRESSION SUICIDAL | 1 0.01 28.52 DEPRESSIVE SYMPTOM | 2 0.02 28.54 DERMAL CYST | 1 0.01 28.55 DERMATITIS ACNEIFORM | 2 0.02 28.57 DERMATITIS ALLERGIC | 3 0.03 28.60 DERMATITIS BULLOUS | 3 0.03 28.63 DERMATITIS CONTACT | 1 0.01 28.64 DERMATITIS EXFOLIATIVE | 3 0.03 28.67 DERMATOMYOSITIS | 1 0.01 28.68 DERMATOPHYTOSIS | 1 0.01 28.69 DETACHED DESCEMET'S MEMBRANE | 1 0.01 28.70 DEVICE FAILURE | 5 0.05 28.75 DEVICE MALFUNCTION | 1 0.01 28.76 DEVICE MIGRATION | 1 0.01 28.77 DEVICE RELATED INFECTION | 1 0.01 28.78 DIABETES MELLITUS | 7 0.07 28.85 DIABETES MELLITUS INADEQUATE CONTROL | 2 0.02 28.87 DIABETES MELLITUS NON-INSULIN-DEPENDENT | 3 0.03 28.90 DIABETIC FOOT | 2 0.02 28.92 DIABETIC FOOT INFECTION | 1 0.01 28.93 DIABETIC KETOACIDOSIS | 5 0.05 28.98 DIABETIC RETINOPATHY | 2 0.02 29.00 DIALYSIS | 11 0.11 29.11 DIARRHOEA | 76 0.76 29.87 DIARRHOEA HAEMORRHAGIC | 3 0.03 29.90 DIFFICULTY IN WALKING | 9 0.09 29.99 DILATATION ATRIAL | 3 0.03 30.02 DILATATION VENTRICULAR | 2 0.02 30.04 DIPLEGIA | 2 0.02 30.06 DIPLOPIA | 7 0.07 30.13 DISABILITY | 1 0.01 30.14 DISCOMFORT | 3 0.03 30.17 DISEASE PROGRESSION | 11 0.11 30.28 DISEASE RECURRENCE | 17 0.17 30.45 DISORIENTATION | 10 0.10 30.55 DISSEMINATED INTRAVASCULAR COAGULATION | 5 0.05 30.60 DISSEMINATED TUBERCULOSIS | 1 0.01 30.61 DISSOCIATION | 3 0.03 30.64 DISTRICHIASIS | 1 0.01 30.65 DISTURBANCE IN ATTENTION | 12 0.12 30.77 DIVERTICULAR HERNIA | 1 0.01 30.78 DIVERTICULAR PERFORATION | 2 0.02 30.80 DIVERTICULITIS | 7 0.07 30.87 DIVERTICULUM | 7 0.07 30.94 DIVERTICULUM INTESTINAL | 4 0.04 30.98 DIZZINESS | 72 0.72 31.70 DIZZINESS POSTURAL | 1 0.01 31.71 DNA ANTIBODY POSITIVE | 1 0.01 31.72 DROOLING | 2 0.02 31.74 DRUG ABUSER | 10 0.10 31.84 DRUG ADMINISTRATION ERROR | 9 0.09 31.93 DRUG DEPENDENCE | 4 0.04 31.97 DRUG DISPENSING ERROR | 12 0.12 32.09 DRUG DOSE OMISSION | 3 0.03 32.12 DRUG EFFECT DECREASED | 7 0.07 32.19 DRUG ERUPTION | 8 0.08 32.27 DRUG EXPOSURE DURING PREGNANCY | 54 0.54 32.81 DRUG EXPOSURE VIA BREAST MILK | 4 0.04 32.85 DRUG HYPERSENSITIVITY | 10 0.10 32.95 DRUG INEFFECTIVE | 72 0.72 33.67 DRUG INTERACTION | 35 0.35 34.02 DRUG INTOLERANCE | 1 0.01 34.03 DRUG LEVEL BELOW THERAPEUTIC | 2 0.02 34.05 DRUG LEVEL DECREASED | 1 0.01 34.06 DRUG LEVEL FLUCTUATING | 1 0.01 34.07 DRUG LEVEL INCREASED | 6 0.06 34.13 DRUG PRESCRIBING ERROR | 2 0.02 34.15 DRUG RASH WITH EOSINOPHILIA AND SYSTE.. | 2 0.02 34.17 DRUG RESISTANCE | 4 0.04 34.21 DRUG TOLERANCE DECREASED | 1 0.01 34.22 DRUG TOXICITY | 31 0.31 34.53 DRUG WITHDRAWAL SYNDROME | 19 0.19 34.72 DRUG WITHDRAWAL SYNDROME NEONATAL | 1 0.01 34.73 DRY EYE | 2 0.02 34.75 DRY MOUTH | 6 0.06 34.81 DRY SKIN | 4 0.04 34.85 DUODENAL ULCER HAEMORRHAGE | 1 0.01 34.86 DUODENITIS | 3 0.03 34.89 DYSARTHRIA | 14 0.14 35.03 DYSGEUSIA | 7 0.07 35.10 DYSGRAPHIA | 1 0.01 35.11 DYSKINESIA | 11 0.11 35.22 DYSLIPIDAEMIA | 1 0.01 35.23 DYSPAREUNIA | 1 0.01 35.24 DYSPEPSIA | 11 0.11 35.35 DYSPHAGIA | 20 0.20 35.55 DYSPHASIA | 3 0.03 35.58 DYSPHEMIA | 3 0.03 35.61 DYSPHONIA | 4 0.04 35.65 DYSPNOEA | 94 0.94 36.59 DYSPNOEA EXERTIONAL | 6 0.06 36.65 DYSPNOEA PAROXYSMAL NOCTURNAL | 1 0.01 36.66 DYSPRAXIA | 1 0.01 36.67 DYSSOMNIA | 1 0.01 36.68 DYSSTASIA | 8 0.08 36.76 DYSTHYMIC DISORDER | 1 0.01 36.77 DYSTONIA | 3 0.03 36.80 DYSURIA | 8 0.08 36.88 EAR CANAL INJURY | 1 0.01 36.89 EAR CONGESTION | 1 0.01 36.90 EAR DISCOMFORT | 1 0.01 36.91 EAR HAEMORRHAGE | 2 0.02 36.93 EAR INFECTION | 5 0.05 36.98 EAR PAIN | 2 0.02 37.00 EARLY MORNING AWAKENING | 1 0.01 37.01 EATING DISORDER | 4 0.04 37.05 ECCHYMOSIS | 6 0.06 37.11 ECHOLALIA | 1 0.01 37.12 ECLAMPSIA | 1 0.01 37.13 ECONOMIC PROBLEM | 4 0.04 37.17 ECZEMA | 7 0.07 37.24 EJECTION FRACTION DECREASED | 4 0.04 37.28 ELECTROCARDIOGRAM ABNORMAL | 4 0.04 37.32 ELECTROCARDIOGRAM CHANGE | 1 0.01 37.33 ELECTROCARDIOGRAM P WAVE ABNORMAL | 1 0.01 37.34 ELECTROCARDIOGRAM POOR R-WAVE PROGRES.. | 1 0.01 37.35 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED | 1 0.01 37.36 ELECTROCARDIOGRAM QT CORRECTED INTERV.. | 3 0.03 37.39 ELECTROCARDIOGRAM QT PROLONGED | 6 0.06 37.45 ELECTROCARDIOGRAM R ON T PHENOMENON | 1 0.01 37.46 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION | 2 0.02 37.48 ELECTROCARDIOGRAM ST SEGMENT ELEVATION | 1 0.01 37.49 ELECTROCARDIOGRAM ST-T CHANGE | 1 0.01 37.50 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL | 1 0.01 37.51 ELECTROCARDIOGRAM T WAVE ABNORMAL | 2 0.02 37.53 ELECTROCARDIOGRAM T WAVE PEAKED | 1 0.01 37.54 ELECTROCARDIOGRAM U-WAVE ABNORMALITY | 1 0.01 37.55 ELECTROENCEPHALOGRAM ABNORMAL | 3 0.03 37.58 ELECTROLYTE IMBALANCE | 1 0.01 37.59 ELECTROMECHANICAL DISSOCIATION | 1 0.01 37.60 EMBOLECTOMY | 1 0.01 37.61 EMBOLISM | 1 0.01 37.62 EMBOLISM VENOUS | 1 0.01 37.63 EMOTIONAL DISORDER | 4 0.04 37.67 EMOTIONAL DISTRESS | 9 0.09 37.76 EMPHYSEMA | 3 0.03 37.79 ENANTHEMA | 1 0.01 37.80 ENCEPHALOMALACIA | 1 0.01 37.81 ENCEPHALOPATHY | 10 0.10 37.91 ENDOCARDITIS | 2 0.02 37.93 ENDODONTIC PROCEDURE | 1 0.01 37.94 ENDOLYMPHATIC HYDROPS | 1 0.01 37.95 ENDOMETRIAL HYPERPLASIA | 1 0.01 37.96 ENDOMETRIAL HYPERTROPHY | 1 0.01 37.97 ENGRAFTMENT SYNDROME | 1 0.01 37.98 ENTEROCOCCAL BACTERAEMIA | 2 0.02 38.00 ENTEROCOCCAL INFECTION | 4 0.04 38.04 ENTEROCOLITIS | 1 0.01 38.05 ENTEROCOLITIS HAEMORRHAGIC | 3 0.03 38.08 EOSINOPHIL COUNT DECREASED | 1 0.01 38.09 EOSINOPHIL COUNT INCREASED | 2 0.02 38.11 EOSINOPHILIA | 11 0.11 38.22 EOSINOPHILIC MYOCARDITIS | 1 0.01 38.23 EOSINOPHILIC PNEUMONIA | 1 0.01 38.24 EPIGLOTTITIS | 2 0.02 38.26 EPILEPSY | 7 0.07 38.33 EPISTAXIS | 14 0.14 38.47 EPSTEIN-BARR VIRUS INFECTION | 2 0.02 38.49 ERECTILE DYSFUNCTION | 4 0.04 38.53 EROSIVE DUODENITIS | 1 0.01 38.54 ERUCTATION | 2 0.02 38.56 ERYSIPELAS | 3 0.03 38.59 ERYTHEMA | 27 0.27 38.86 ERYTHEMA ANNULARE | 1 0.01 38.87 ERYTHEMA MULTIFORME | 7 0.07 38.94 ERYTHROBLAST COUNT INCREASED | 1 0.01 38.95 ESCHERICHIA INFECTION | 4 0.04 38.99 EUPHORIC MOOD | 4 0.04 39.03 EXCITABILITY | 2 0.02 39.05 EXCORIATION | 1 0.01 39.06 EXERCISE CAPACITY DECREASED | 1 0.01 39.07 EXERCISE TOLERANCE DECREASED | 1 0.01 39.08 EXFOLIATIVE RASH | 1 0.01 39.09 EXOPHTHALMOS | 1 0.01 39.10 EXPRESSIVE LANGUAGE DISORDER | 1 0.01 39.11 EXSANGUINATION | 2 0.02 39.13 EXTRAPYRAMIDAL DISORDER | 2 0.02 39.15 EXTRASYSTOLES | 3 0.03 39.18 EYE DISORDER | 5 0.05 39.23 EYE HAEMORRHAGE | 5 0.05 39.28 EYE INFECTION | 1 0.01 39.29 EYE INFLAMMATION | 2 0.02 39.31 EYE IRRITATION | 2 0.02 39.33 EYE MOVEMENT DISORDER | 3 0.03 39.36 EYE PAIN | 6 0.06 39.42 EYE PRURITUS | 1 0.01 39.43 EYE ROLLING | 1 0.01 39.44 EYE SWELLING | 3 0.03 39.47 EYELID DISORDER | 2 0.02 39.49 EYELID FUNCTION DISORDER | 1 0.01 39.50 EYELID MARGIN CRUSTING | 1 0.01 39.51 EYELID OEDEMA | 4 0.04 39.55 EYELID OPERATION | 1 0.01 39.56 EYELID PAIN | 1 0.01 39.57 EYELID PTOSIS | 5 0.05 39.62 FACE INJURY | 1 0.01 39.63 FACE OEDEMA | 5 0.05 39.68 FACIAL DYSMORPHISM | 1 0.01 39.69 FACIAL NEURALGIA | 1 0.01 39.70 FACIAL PAIN | 1 0.01 39.71 FACIAL PALSY | 2 0.02 39.73 FACTOR VIII INHIBITION | 2 0.02 39.75 FAECAL INCONTINENCE | 2 0.02 39.77 FAECALOMA | 1 0.01 39.78 FAECES DISCOLOURED | 9 0.09 39.87 FAECES PALE | 2 0.02 39.89 FALL | 49 0.49 40.38 FALLOPIAN TUBE CYST | 1 0.01 40.39 FALSE POSITIVE LABORATORY RESULT | 1 0.01 40.40 FAMILY STRESS | 2 0.02 40.42 FAT NECROSIS | 1 0.01 40.43 FATIGUE | 75 0.75 41.18 FEAR | 8 0.08 41.26 FEBRILE NEUTROPENIA | 12 0.12 41.38 FEEDING DISORDER | 4 0.04 41.42 FEEDING DISORDER NEONATAL | 4 0.04 41.46 FEELING ABNORMAL | 23 0.23 41.69 FEELING COLD | 4 0.04 41.73 FEELING DRUNK | 2 0.02 41.75 FEELING HOT | 2 0.02 41.77 FEELING JITTERY | 2 0.02 41.79 FEELINGS OF WORTHLESSNESS | 2 0.02 41.81 FEMORAL ARTERIAL STENOSIS | 1 0.01 41.82 FEMORAL NECK FRACTURE | 2 0.02 41.84 FIBRIN D DIMER INCREASED | 1 0.01 41.85 FIBRINOLYSIS INCREASED | 1 0.01 41.86 FIBROCYSTIC BREAST DISEASE | 1 0.01 41.87 FIBROMUSCULAR DYSPLASIA | 1 0.01 41.88 FIBROMYALGIA | 6 0.06 41.94 FIBROSIS | 1 0.01 41.95 FINGER DEFORMITY | 1 0.01 41.96 FISTULA | 4 0.04 42.00 FLANK PAIN | 2 0.02 42.02 FLATULENCE | 7 0.07 42.09 FLUID OVERLOAD | 3 0.03 42.12 FLUID RETENTION | 6 0.06 42.18 FLUSHING | 7 0.07 42.25 FOAMING AT MOUTH | 2 0.02 42.27 FOETAL ARRHYTHMIA | 1 0.01 42.28 FOETAL DISORDER | 1 0.01 42.29 FOLATE DEFICIENCY | 1 0.01 42.30 FOOT FRACTURE | 2 0.02 42.32 FOOT OPERATION | 1 0.01 42.33 FOREIGN BODY TRAUMA | 2 0.02 42.35 FORMICATION | 2 0.02 42.37 FRACTURE | 1 0.01 42.38 FRACTURED SACRUM | 1 0.01 42.39 FREEZING PHENOMENON | 1 0.01 42.40 FREQUENT BOWEL MOVEMENTS | 1 0.01 42.41 FULL BLOOD COUNT ABNORMAL | 2 0.02 42.43 FUNGAEMIA | 1 0.01 42.44 FUNGAL INFECTION | 3 0.03 42.47 FUNGUS SEROLOGY TEST POSITIVE | 1 0.01 42.48 FURUNCLE | 1 0.01 42.49 GAIT DISTURBANCE | 12 0.12 42.61 GALLBLADDER DISORDER | 3 0.03 42.64 GALLBLADDER PERFORATION | 1 0.01 42.65 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL | 1 0.01 42.66 GAMMA-GLUTAMYLTRANSFERASE INCREASED | 19 0.19 42.85 GASTRIC CANCER | 2 0.02 42.87 GASTRIC DISORDER | 5 0.05 42.92 GASTRIC HAEMORRHAGE | 1 0.01 42.93 GASTRIC OPERATION | 1 0.01 42.94 GASTRIC ULCER | 5 0.05 42.99 GASTRIC ULCER HAEMORRHAGE | 1 0.01 43.00 GASTRIC ULCER PERFORATION | 1 0.01 43.01 GASTRITIS | 12 0.12 43.13 GASTRITIS ATROPHIC | 1 0.01 43.14 GASTRITIS EROSIVE | 2 0.02 43.16 GASTRITIS HAEMORRHAGIC | 1 0.01 43.17 GASTROENTERITIS | 10 0.10 43.27 GASTROENTERITIS VIRAL | 1 0.01 43.28 GASTROINTESTINAL DISORDER | 22 0.22 43.50 GASTROINTESTINAL EROSION | 1 0.01 43.51 GASTROINTESTINAL HAEMORRHAGE | 18 0.18 43.69 GASTROINTESTINAL MALFORMATION | 2 0.02 43.71 GASTROINTESTINAL MOTILITY DISORDER | 2 0.02 43.73 GASTROINTESTINAL MUCOSAL DISORDER | 1 0.01 43.74 GASTROINTESTINAL NECROSIS | 2 0.02 43.76 GASTROINTESTINAL PERFORATION | 1 0.01 43.77 GASTROINTESTINAL TUBE INSERTION | 1 0.01 43.78 GASTROOESOPHAGEAL REFLUX DISEASE | 14 0.14 43.92 GENE MUTATION IDENTIFICATION TEST POS.. | 2 0.02 43.94 GENERAL NUTRITION DISORDER | 1 0.01 43.95 GENERAL PHYSICAL CONDITION | 1 0.01 43.96 GENERAL PHYSICAL CONDITION ABNORMAL | 1 0.01 43.97 GENERAL PHYSICAL HEALTH DETERIORATION | 16 0.16 44.13 GENERAL SYMPTOM | 2 0.02 44.15 GENERALISED ANXIETY DISORDER | 1 0.01 44.16 GENERALISED ERYTHEMA | 5 0.05 44.21 GENERALISED OEDEMA | 3 0.03 44.24 GENITAL LESION | 1 0.01 44.25 GENITOURINARY TRACT NEOPLASM | 1 0.01 44.26 GESTATIONAL DIABETES | 3 0.03 44.29 GILBERT'S SYNDROME | 1 0.01 44.30 GINGIVAL BLEEDING | 3 0.03 44.33 GINGIVAL EROSION | 1 0.01 44.34 GINGIVAL INJURY | 1 0.01 44.35 GINGIVAL OEDEMA | 2 0.02 44.37 GINGIVAL PAIN | 4 0.04 44.41 GINGIVAL RECESSION | 2 0.02 44.43 GINGIVAL SWELLING | 1 0.01 44.44 GINGIVITIS | 3 0.03 44.47 GLAUCOMA | 8 0.08 44.55 GLOMERULAR FILTRATION RATE DECREASED | 1 0.01 44.56 GLOMERULAR VASCULAR DISORDER | 1 0.01 44.57 GLOMERULONEPHRITIS | 1 0.01 44.58 GLOMERULOSCLEROSIS | 2 0.02 44.60 GLOSSODYNIA | 2 0.02 44.62 GLUTAMATE DEHYDROGENASE INCREASED | 1 0.01 44.63 GLYCOSYLATED HAEMOGLOBIN INCREASED | 1 0.01 44.64 GOITRE | 2 0.02 44.66 GOUT | 1 0.01 44.67 GOUTY ARTHRITIS | 1 0.01 44.68 GRAFT DYSFUNCTION | 1 0.01 44.69 GRAFT VERSUS HOST DISEASE | 7 0.07 44.76 GRAND MAL CONVULSION | 10 0.10 44.86 GRANULOMA | 3 0.03 44.89 GRANULOMATOUS LIVER DISEASE | 1 0.01 44.90 GRAVITATIONAL OEDEMA | 1 0.01 44.91 GRIP STRENGTH DECREASED | 1 0.01 44.92 GROWTH RETARDATION | 1 0.01 44.93 GUILLAIN-BARRE SYNDROME | 3 0.03 44.96 GUM NEOPLASM MALIGNANT STAGE UNSPECIF.. | 1 0.01 44.97 GYNAECOMASTIA | 3 0.03 45.00 HAEMANGIOMA | 4 0.04 45.04 HAEMATEMESIS | 13 0.13 45.17 HAEMATOCHEZIA | 8 0.08 45.25 HAEMATOCRIT DECREASED | 8 0.08 45.33 HAEMATOCRIT INCREASED | 1 0.01 45.34 HAEMATOMA | 8 0.08 45.42 HAEMATURIA | 11 0.11 45.53 HAEMODIALYSIS | 5 0.05 45.58 HAEMODYNAMIC INSTABILITY | 1 0.01 45.59 HAEMOGLOBIN ABNORMAL | 1 0.01 45.60 HAEMOGLOBIN DECREASED | 26 0.26 45.86 HAEMOGLOBIN INCREASED | 1 0.01 45.87 HAEMOLYSIS | 9 0.09 45.96 HAEMOLYTIC ANAEMIA | 13 0.13 46.09 HAEMOLYTIC URAEMIC SYNDROME | 9 0.09 46.18 HAEMOPTYSIS | 5 0.05 46.23 HAEMORRHAGE | 15 0.15 46.38 HAEMORRHAGE INTRACRANIAL | 2 0.02 46.40 HAEMORRHAGE URINARY TRACT | 1 0.01 46.41 HAEMORRHAGIC TRANSFORMATION STROKE | 1 0.01 46.42 HAEMORRHOIDS | 9 0.09 46.51 HAIR DISORDER | 1 0.01 46.52 HAIR GROWTH ABNORMAL | 1 0.01 46.53 HAIR TEXTURE ABNORMAL | 1 0.01 46.54 HALLUCINATION | 17 0.17 46.71 HALLUCINATION, AUDITORY | 4 0.04 46.75 HALLUCINATION, VISUAL | 3 0.03 46.78 HAND DERMATITIS | 1 0.01 46.79 HAPTOGLOBIN | 1 0.01 46.80 HAPTOGLOBIN DECREASED | 2 0.02 46.82 HEAD INJURY | 3 0.03 46.85 HEADACHE | 72 0.72 47.57 HEARING IMPAIRED | 1 0.01 47.58 HEART DISEASE CONGENITAL | 3 0.03 47.61 HEART INJURY | 1 0.01 47.62 HEART RATE DECREASED | 5 0.05 47.67 HEART RATE INCREASED | 15 0.15 47.82 HEART RATE IRREGULAR | 2 0.02 47.84 HEART TRANSPLANT | 1 0.01 47.85 HEART TRANSPLANT REJECTION | 1 0.01 47.86 HEART VALVE STENOSIS | 1 0.01 47.87 HEAT STROKE | 1 0.01 47.88 HELICOBACTER GASTRITIS | 1 0.01 47.89 HELICOBACTER PYLORI IDENTIFICATION TE.. | 1 0.01 47.90 HEMIANOPIA | 2 0.02 47.92 HEMIPARESIS | 7 0.07 47.99 HEMIPLEGIA | 3 0.03 48.02 HENOCH-SCHONLEIN PURPURA | 3 0.03 48.05 HEPARIN-INDUCED THROMBOCYTOPENIA | 3 0.03 48.08 HEPATIC ATROPHY | 2 0.02 48.10 HEPATIC CIRRHOSIS | 2 0.02 48.12 HEPATIC ENCEPHALOPATHY | 1 0.01 48.13 HEPATIC ENZYME ABNORMAL | 2 0.02 48.15 HEPATIC ENZYME INCREASED | 8 0.08 48.23 HEPATIC FAILURE | 14 0.14 48.37 HEPATIC FIBROSIS | 2 0.02 48.39 HEPATIC FUNCTION ABNORMAL | 14 0.14 48.53 HEPATIC INFARCTION | 1 0.01 48.54 HEPATIC LESION | 1 0.01 48.55 HEPATIC NECROSIS | 4 0.04 48.59 HEPATIC NEOPLASM | 1 0.01 48.60 HEPATIC PAIN | 2 0.02 48.62 HEPATIC RUPTURE | 1 0.01 48.63 HEPATIC STEATOSIS | 3 0.03 48.66 HEPATIC TRAUMA | 11 0.11 48.77 HEPATITIS | 19 0.19 48.96 HEPATITIS A | 1 0.01 48.97 HEPATITIS A ANTIBODY POSITIVE | 1 0.01 48.98 HEPATITIS ACUTE | 8 0.08 49.06 HEPATITIS B | 7 0.07 49.13 HEPATITIS B SURFACE ANTIGEN POSITIVE | 1 0.01 49.14 HEPATITIS B VIRUS | 1 0.01 49.15 HEPATITIS C | 7 0.07 49.22 HEPATITIS CHOLESTATIC | 4 0.04 49.26 HEPATITIS CHRONIC ACTIVE | 1 0.01 49.27 HEPATITIS FULMINANT | 2 0.02 49.29 HEPATITIS TOXIC | 1 0.01 49.30 HEPATO-LENTICULAR DEGENERATION | 1 0.01 49.31 HEPATOCELLULAR DAMAGE | 8 0.08 49.39 HEPATOMEGALY | 18 0.18 49.57 HEPATOTOXICITY | 5 0.05 49.62 HERNIA | 2 0.02 49.64 HERNIA REPAIR | 2 0.02 49.66 HERPES SIMPLEX | 3 0.03 49.69 HERPES VIRUS INFECTION | 1 0.01 49.70 HERPES ZOSTER | 7 0.07 49.77 HIATUS HERNIA | 11 0.11 49.88 HIDRADENITIS | 1 0.01 49.89 HIGH-PITCHED CRYING | 1 0.01 49.90 HIP ARTHROPLASTY | 3 0.03 49.93 HIP FRACTURE | 1 0.01 49.94 HIP SURGERY | 1 0.01 49.95 HIRSUTISM | 1 0.01 49.96 HISTAMINE ABNORMAL | 1 0.01 49.97 HISTIOCYTOSIS HAEMATOPHAGIC | 2 0.02 49.99 HODGKIN'S DISEASE | 1 0.01 50.00 HODGKIN'S DISEASE MIXED CELLULARITY S.. | 1 0.01 50.01 HOMICIDAL IDEATION | 1 0.01 50.02 HORDEOLUM | 2 0.02 50.04 HOSPITALISATION | 4 0.04 50.08 HOSTILITY | 2 0.02 50.10 HOT FLUSH | 1 0.01 50.11 HUMAN HERPES VIRUS 6 SEROLOGY POSITIVE | 1 0.01 50.12 HUMORAL IMMUNE DEFECT | 1 0.01 50.13 HYDROCEPHALUS | 1 0.01 50.14 HYDRONEPHROSIS | 4 0.04 50.18 HYPERACUSIS | 2 0.02 50.20 HYPERAEMIA | 1 0.01 50.21 HYPERAMMONAEMIA | 1 0.01 50.22 HYPERAMYLASAEMIA | 1 0.01 50.23 HYPERBILIRUBINAEMIA | 2 0.02 50.25 HYPERCAPNIA | 1 0.01 50.26 HYPERCHOLESTEROLAEMIA | 5 0.05 50.31 HYPEREOSINOPHILIC SYNDROME | 1 0.01 50.32 HYPERGLYCAEMIA | 15 0.15 50.47 HYPERHIDROSIS | 20 0.20 50.67 HYPERKALAEMIA | 10 0.10 50.77 HYPERLACTACIDAEMIA | 1 0.01 50.78 HYPERLIPIDAEMIA | 9 0.09 50.87 HYPERMETABOLISM | 1 0.01 50.88 HYPERMETROPIA | 1 0.01 50.89 HYPERPLASIA | 1 0.01 50.90 HYPERPLASTIC CHOLECYSTOPATHY | 1 0.01 50.91 HYPERPROLACTINAEMIA | 1 0.01 50.92 HYPERPYREXIA | 1 0.01 50.93 HYPERREFLEXIA | 1 0.01 50.94 HYPERSENSITIVITY | 22 0.22 51.16 HYPERSOMNIA | 2 0.02 51.18 HYPERTENSION | 53 0.53 51.71 HYPERTENSIVE CRISIS | 6 0.06 51.77 HYPERTENSIVE ENCEPHALOPATHY | 1 0.01 51.78 HYPERTENSIVE HEART DISEASE | 2 0.02 51.80 HYPERTHERMIA | 2 0.02 51.82 HYPERTHYROIDISM | 3 0.03 51.85 HYPERTONIA | 2 0.02 51.87 HYPERTONIC BLADDER | 3 0.03 51.90 HYPERTRIGLYCERIDAEMIA | 13 0.13 52.03 HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY | 1 0.01 52.04 HYPERTROPHY BREAST | 2 0.02 52.06 HYPERURICAEMIA | 1 0.01 52.07 HYPERVENTILATION | 4 0.04 52.11 HYPOACUSIS | 4 0.04 52.15 HYPOAESTHESIA | 23 0.23 52.38 HYPOAESTHESIA ORAL | 3 0.03 52.41 HYPOALBUMINAEMIA | 2 0.02 52.43 HYPOCALCAEMIA | 4 0.04 52.47 HYPOCHLORAEMIA | 1 0.01 52.48 HYPOCOAGULABLE STATE | 1 0.01 52.49 HYPOGAMMAGLOBULINAEMIA | 2 0.02 52.51 HYPOGEUSIA | 1 0.01 52.52 HYPOGLYCAEMIA | 11 0.11 52.63 HYPOGLYCAEMIA NEONATAL | 2 0.02 52.65 HYPOKALAEMIA | 11 0.11 52.76 HYPOKINESIA | 5 0.05 52.81 HYPOMAGNESAEMIA | 2 0.02 52.83 HYPONATRAEMIA | 14 0.14 52.97 HYPOPHOSPHATAEMIA | 1 0.01 52.98 HYPOREFLEXIA | 1 0.01 52.99 HYPOTENSION | 36 0.36 53.35 HYPOTHERMIA | 5 0.05 53.40 HYPOTHYROIDISM | 4 0.04 53.44 HYPOTONIA | 4 0.04 53.48 HYPOTONIA NEONATAL | 2 0.02 53.50 HYPOTRICHOSIS | 2 0.02 53.52 HYPOVENTILATION | 1 0.01 53.53 HYPOVOLAEMIA | 2 0.02 53.55 HYPOVOLAEMIC SHOCK | 1 0.01 53.56 HYPOXIA | 13 0.13 53.69 HYSTERECTOMY | 3 0.03 53.72 IATROGENIC INJURY | 1 0.01 53.73 IDIOPATHIC PULMONARY FIBROSIS | 1 0.01 53.74 IDIOPATHIC THROMBOCYTOPENIC PURPURA | 2 0.02 53.76 IDIOPATHIC URTICARIA | 1 0.01 53.77 IIIRD NERVE PARALYSIS | 1 0.01 53.78 ILEAL STENOSIS | 1 0.01 53.79 ILEAL ULCER | 1 0.01 53.80 ILEITIS | 3 0.03 53.83 ILEUS | 5 0.05 53.88 ILEUS PARALYTIC | 2 0.02 53.90 ILIAC ARTERY STENOSIS | 1 0.01 53.91 ILIAC VEIN THROMBOSIS | 1 0.01 53.92 ILL-DEFINED DISORDER | 16 0.16 54.08 IMMUNE RECONSTITUTION SYNDROME | 2 0.02 54.10 IMMUNE SYSTEM DISORDER | 2 0.02 54.12 IMMUNOSUPPRESSION | 2 0.02 54.14 IMPAIRED DRIVING ABILITY | 1 0.01 54.15 IMPAIRED HEALING | 10 0.10 54.25 IMPAIRED WORK ABILITY | 2 0.02 54.27 IMPETIGO | 1 0.01 54.28 IMPLANT SITE MASS | 1 0.01 54.29 IMPLANTABLE DEFIBRILLATOR MALFUNCTION | 1 0.01 54.30 IMPULSE-CONTROL DISORDER | 1 0.01 54.31 IMPULSIVE BEHAVIOUR | 3 0.03 54.34 INADEQUATE ANALGESIA | 1 0.01 54.35 INADEQUATE DIET | 1 0.01 54.36 INADEQUATE LUBRICATION | 1 0.01 54.37 INAPPROPRIATE AFFECT | 1 0.01 54.38 INAPPROPRIATE ANTIDIURETIC HORMONE SE.. | 2 0.02 54.40 INAPPROPRIATE SCHEDULE OF DRUG ADMINI.. | 1 0.01 54.41 INCISION SITE HAEMORRHAGE | 2 0.02 54.43 INCOHERENT | 2 0.02 54.45 INCONTINENCE | 4 0.04 54.49 INCORRECT DOSE ADMINISTERED | 12 0.12 54.61 INCORRECT DRUG ADMINISTRATION RATE | 1 0.01 54.62 INCORRECT ROUTE OF DRUG ADMINISTRATION | 1 0.01 54.63 INCREASED TENDENCY TO BRUISE | 2 0.02 54.65 INCREASED UPPER AIRWAY SECRETION | 1 0.01 54.66 INDURATION | 1 0.01 54.67 INFARCTION | 2 0.02 54.69 INFECTION | 14 0.14 54.83 INFECTION IN AN IMMUNOCOMPROMISED HOST | 1 0.01 54.84 INFLAMMATION | 13 0.13 54.97 INFLAMMATORY BOWEL DISEASE | 19 0.19 55.16 INFLUENZA | 10 0.10 55.26 INFLUENZA LIKE ILLNESS | 12 0.12 55.38 INFREQUENT BOWEL MOVEMENTS | 1 0.01 55.39 INFUSION RELATED REACTION | 12 0.12 55.51 INFUSION SITE ERYTHEMA | 1 0.01 55.52 INFUSION SITE PRURITUS | 1 0.01 55.53 INGUINAL HERNIA | 2 0.02 55.55 INITIAL INSOMNIA | 1 0.01 55.56 INJECTION SITE ABSCESS | 1 0.01 55.57 INJECTION SITE ERYTHEMA | 9 0.09 55.66 INJECTION SITE HAEMORRHAGE | 3 0.03 55.69 INJECTION SITE INDURATION | 1 0.01 55.70 INJECTION SITE IRRITATION | 2 0.02 55.72 INJECTION SITE NECROSIS | 1 0.01 55.73 INJECTION SITE PAIN | 2 0.02 55.75 INJECTION SITE PRURITUS | 2 0.02 55.77 INJECTION SITE RASH | 1 0.01 55.78 INJECTION SITE REACTION | 4 0.04 55.82 INJECTION SITE ULCER | 2 0.02 55.84 INJECTION SITE URTICARIA | 1 0.01 55.85 INJURY | 21 0.21 56.06 INJURY ASPHYXIATION | 5 0.05 56.11 INSOMNIA | 38 0.38 56.49 INTENTION TREMOR | 1 0.01 56.50 INTENTIONAL MISUSE | 19 0.19 56.69 INTENTIONAL SELF-INJURY | 4 0.04 56.73 INTERCEPTED MEDICATION ERROR | 4 0.04 56.77 INTERMITTENT CLAUDICATION | 2 0.02 56.79 INTERNAL INJURY | 2 0.02 56.81 INTERNATIONAL NORMALISED RATIO ABNORMAL | 1 0.01 56.82 INTERNATIONAL NORMALISED RATIO INCREA.. | 9 0.09 56.91 INTERSTITIAL LUNG DISEASE | 15 0.15 57.06 INTERVERTEBRAL DISC COMPRESSION | 1 0.01 57.07 INTERVERTEBRAL DISC DEGENERATION | 3 0.03 57.10 INTERVERTEBRAL DISC DISORDER | 2 0.02 57.12 INTERVERTEBRAL DISC OPERATION | 3 0.03 57.15 INTERVERTEBRAL DISC PROTRUSION | 3 0.03 57.18 INTESTINAL FISTULA | 1 0.01 57.19 INTESTINAL GANGRENE | 1 0.01 57.20 INTESTINAL HAEMORRHAGE | 21 0.21 57.41 INTESTINAL INFARCTION | 1 0.01 57.42 INTESTINAL ISCHAEMIA | 3 0.03 57.45 INTESTINAL OBSTRUCTION | 6 0.06 57.51 INTESTINAL PERFORATION | 2 0.02 57.53 INTESTINAL ULCER | 1 0.01 57.54 INTESTINAL VILLI ATROPHY | 1 0.01 57.55 INTRACARDIAC THROMBUS | 3 0.03 57.58 INTRACRANIAL ANEURYSM | 3 0.03 57.61 INTRACRANIAL PRESSURE INCREASED | 2 0.02 57.63 INTRAOCULAR PRESSURE INCREASED | 2 0.02 57.65 INTRAVENTRICULAR HAEMORRHAGE | 1 0.01 57.66 INTUSSUSCEPTION | 1 0.01 57.67 IRIS ADHESIONS | 1 0.01 57.68 IRON DEFICIENCY | 3 0.03 57.71 IRON DEFICIENCY ANAEMIA | 6 0.06 57.77 IRRITABILITY | 9 0.09 57.86 IRRITABLE BOWEL SYNDROME | 10 0.10 57.96 ISCHAEMIA | 3 0.03 57.99 ISCHAEMIC CARDIOMYOPATHY | 2 0.02 58.01 ISCHAEMIC CEREBRAL INFARCTION | 1 0.01 58.02 ISCHAEMIC HEPATITIS | 2 0.02 58.04 ISCHAEMIC STROKE | 9 0.09 58.13 IVTH NERVE PARALYSIS | 1 0.01 58.14 JAUNDICE | 19 0.19 58.33 JAUNDICE CHOLESTATIC | 3 0.03 58.36 JAUNDICE NEONATAL | 2 0.02 58.38 JAW DISORDER | 2 0.02 58.40 JAW OPERATION | 1 0.01 58.41 JEJUNAL PERFORATION | 2 0.02 58.43 JOINT CONTRACTURE | 1 0.01 58.44 JOINT DISLOCATION | 3 0.03 58.47 JOINT INJURY | 1 0.01 58.48 JOINT SPRAIN | 2 0.02 58.50 JOINT STIFFNESS | 2 0.02 58.52 JOINT SWELLING | 11 0.11 58.63 KERATITIS | 2 0.02 58.65 KERATITIS HERPETIC | 1 0.01 58.66 KIDNEY INFECTION | 3 0.03 58.69 KIDNEY TRANSPLANT REJECTION | 4 0.04 58.73 KLEBSIELLA BACTERAEMIA | 1 0.01 58.74 KLEBSIELLA INFECTION | 2 0.02 58.76 KNEE ARTHROPLASTY | 3 0.03 58.79 KNEE DEFORMITY | 1 0.01 58.80 KORSAKOFF'S PSYCHOSIS NON-ALCOHOLIC | 1 0.01 58.81 KUSSMAUL RESPIRATION | 1 0.01 58.82 KYPHOSIS | 1 0.01 58.83 LABORATORY TEST ABNORMAL | 10 0.10 58.93 LABYRINTHITIS | 2 0.02 58.95 LACRIMATION INCREASED | 3 0.03 58.98 LACTATE PYRUVATE RATIO INCREASED | 2 0.02 59.00 LACTIC ACIDOSIS | 8 0.08 59.08 LACUNAR INFARCTION | 4 0.04 59.12 LARGE FOR DATES BABY | 1 0.01 59.13 LARGE INTESTINAL STRICTURE | 1 0.01 59.14 LARGE INTESTINE PERFORATION | 4 0.04 59.18 LARYNGEAL DYSPNOEA | 1 0.01 59.19 LARYNGEAL OEDEMA | 1 0.01 59.20 LARYNGEAL STENOSIS | 1 0.01 59.21 LARYNGOSPASM | 1 0.01 59.22 LEARNING DISABILITY | 1 0.01 59.23 LEFT VENTRICULAR FAILURE | 4 0.04 59.27 LEG AMPUTATION | 1 0.01 59.28 LEGAL PROBLEM | 1 0.01 59.29 LEGIONELLA INFECTION | 1 0.01 59.30 LEIOMYOMA | 1 0.01 59.31 LENS DISORDER | 1 0.01 59.32 LENTICULAR OPACITIES | 1 0.01 59.33 LETHARGY | 10 0.10 59.43 LEUKAEMIA | 2 0.02 59.45 LEUKAEMIA RECURRENT | 1 0.01 59.46 LEUKOCYTOCLASTIC VASCULITIS | 5 0.05 59.51 LEUKOCYTOSIS | 7 0.07 59.58 LEUKOCYTURIA | 1 0.01 59.59 LEUKOENCEPHALOPATHY | 1 0.01 59.60 LEUKOPENIA | 17 0.17 59.77 LIBIDO DECREASED | 2 0.02 59.79 LIBIDO INCREASED | 2 0.02 59.81 LICHEN PLANUS | 1 0.01 59.82 LICHENOID KERATOSIS | 1 0.01 59.83 LIGAMENT SPRAIN | 2 0.02 59.85 LIGHT CHAIN ANALYSIS INCREASED | 1 0.01 59.86 LIMB DISCOMFORT | 5 0.05 59.91 LIMB HYPOPLASIA CONGENITAL | 1 0.01 59.92 LIMB INJURY | 2 0.02 59.94 LIMB MALFORMATION | 1 0.01 59.95 LIMB REDUCTION DEFECT | 1 0.01 59.96 LINEAR IGA DISEASE | 1 0.01 59.97 LIP DRY | 1 0.01 59.98 LIPASE INCREASED | 5 0.05 60.03 LIPOMA | 1 0.01 60.04 LIVE BIRTH | 1 0.01 60.05 LIVER ABSCESS | 1 0.01 60.06 LIVER DISORDER | 16 0.16 60.22 LIVER FUNCTION TEST ABNORMAL | 22 0.22 60.44 LIVER TENDERNESS | 1 0.01 60.45 LIVER TRANSPLANT | 1 0.01 60.46 LOBAR PNEUMONIA | 2 0.02 60.48 LOCAL SWELLING | 2 0.02 60.50 LOCALISED INFECTION | 2 0.02 60.52 LOCALISED OEDEMA | 2 0.02 60.54 LOOSE BODY IN JOINT | 1 0.01 60.55 LOSS OF CONSCIOUSNESS | 47 0.47 61.02 LOSS OF EMPLOYMENT | 2 0.02 61.04 LOSS OF LIBIDO | 1 0.01 61.05 LOW DENSITY LIPOPROTEIN INCREASED | 1 0.01 61.06 LOW SET EARS | 1 0.01 61.07 LOWER EXTREMITY MASS | 1 0.01 61.08 LOWER LIMB FRACTURE | 4 0.04 61.12 LOWER RESPIRATORY TRACT INFECTION | 5 0.05 61.17 LUMBAR PUNCTURE ABNORMAL | 1 0.01 61.18 LUMBAR RADICULOPATHY | 2 0.02 61.20 LUMBAR SPINAL STENOSIS | 1 0.01 61.21 LUMBAR VERTEBRAL FRACTURE | 3 0.03 61.24 LUNG ABSCESS | 1 0.01 61.25 LUNG CONSOLIDATION | 1 0.01 61.26 LUNG DISORDER | 5 0.05 61.31 LUNG INFECTION | 6 0.06 61.37 LUNG INFILTRATION | 7 0.07 61.44 LUNG NEOPLASM | 4 0.04 61.48 LUNG NEOPLASM MALIGNANT | 5 0.05 61.53 LUNG TRANSPLANT REJECTION | 1 0.01 61.54 LUPUS-LIKE SYNDROME | 1 0.01 61.55 LYMPHADENOPATHY | 9 0.09 61.64 LYMPHOCELE | 1 0.01 61.65 LYMPHOCYTE COUNT DECREASED | 1 0.01 61.66 LYMPHOCYTE COUNT INCREASED | 1 0.01 61.67 LYMPHOCYTE PERCENTAGE ABNORMAL | 1 0.01 61.68 LYMPHOCYTE PERCENTAGE DECREASED | 1 0.01 61.69 LYMPHOCYTE STIMULATION TEST POSITIVE | 3 0.03 61.72 LYMPHOCYTIC INFILTRATION | 1 0.01 61.73 LYMPHOCYTOSIS | 1 0.01 61.74 LYMPHOEDEMA | 1 0.01 61.75 LYMPHOID TISSUE HYPERPLASIA | 1 0.01 61.76 LYMPHOMA | 1 0.01 61.77 LYMPHOPENIA | 5 0.05 61.82 MACROCYTOSIS | 7 0.07 61.89 MACULAR DEGENERATION | 4 0.04 61.93 MACULAR HOLE | 1 0.01 61.94 MACULAR OEDEMA | 2 0.02 61.96 MACULOPATHY | 1 0.01 61.97 MAJOR DEPRESSION | 1 0.01 61.98 MALABSORPTION | 1 0.01 61.99 MALAISE | 39 0.39 62.38 MALIGNANT HYPERTENSION | 1 0.01 62.39 MALIGNANT MELANOMA | 2 0.02 62.41 MALIGNANT MELANOMA IN SITU | 1 0.01 62.42 MALIGNANT NEOPLASM PROGRESSION | 15 0.15 62.57 MALNUTRITION | 4 0.04 62.61 MANIA | 4 0.04 62.65 MARASMUS | 1 0.01 62.66 MARITAL PROBLEM | 1 0.01 62.67 MATERNAL USE OF ILLICIT DRUGS | 1 0.01 62.68 MEAN CELL VOLUME ABNORMAL | 2 0.02 62.70 MEAN CELL VOLUME DECREASED | 1 0.01 62.71 MEAN CELL VOLUME INCREASED | 2 0.02 62.73 MECONIUM ABNORMAL | 1 0.01 62.74 MEDICATION ERROR | 36 0.36 63.10 MEDICATION TAMPERING | 1 0.01 63.11 MELAENA | 7 0.07 63.18 MEMORY IMPAIRMENT | 13 0.13 63.31 MENINGIOMA | 1 0.01 63.32 MENINGITIS | 1 0.01 63.33 MENINGITIS ASEPTIC | 2 0.02 63.35 MENINGITIS TUBERCULOUS | 1 0.01 63.36 MENISCUS LESION | 1 0.01 63.37 MENORRHAGIA | 3 0.03 63.40 MENSTRUAL DISORDER | 1 0.01 63.41 MENSTRUATION IRREGULAR | 4 0.04 63.45 MENTAL DISORDER | 3 0.03 63.48 MENTAL IMPAIRMENT | 5 0.05 63.53 MENTAL STATUS CHANGES | 11 0.11 63.64 MESENTERIC VEIN THROMBOSIS | 1 0.01 63.65 METABOLIC ACIDOSIS | 6 0.06 63.71 METABOLIC ALKALOSIS | 1 0.01 63.72 METABOLIC DISORDER | 7 0.07 63.79 METABOLIC ENCEPHALOPATHY | 2 0.02 63.81 METABOLIC FUNCTION TEST | 2 0.02 63.83 METABOLIC FUNCTION TEST ABNORMAL | 1 0.01 63.84 METAMORPHOPSIA | 1 0.01 63.85 METASTASES TO BONE | 5 0.05 63.90 METASTASES TO CENTRAL NERVOUS SYSTEM | 1 0.01 63.91 METASTASES TO LIVER | 3 0.03 63.94 METASTASES TO LUNG | 1 0.01 63.95 METASTASES TO LYMPH NODES | 2 0.02 63.97 METASTASES TO PANCREAS | 1 0.01 63.98 METASTASIS | 1 0.01 63.99 METASTATIC BRONCHIAL CARCINOMA | 1 0.01 64.00 METHAEMOGLOBINAEMIA | 1 0.01 64.01 METRORRHAGIA | 1 0.01 64.02 MICROANGIOPATHY | 1 0.01 64.03 MICROCYTIC ANAEMIA | 2 0.02 64.05 MICROCYTOSIS | 3 0.03 64.08 MIDDLE INSOMNIA | 1 0.01 64.09 MIGRAINE | 12 0.12 64.21 MITRAL VALVE CALCIFICATION | 1 0.01 64.22 MITRAL VALVE INCOMPETENCE | 8 0.08 64.30 MITRAL VALVE SCLEROSIS | 1 0.01 64.31 MITRAL VALVE STENOSIS | 2 0.02 64.33 MIXED CONNECTIVE TISSUE DISEASE | 1 0.01 64.34 MOBILITY DECREASED | 6 0.06 64.40 MONARTHRITIS | 1 0.01 64.41 MONOCYTE COUNT DECREASED | 1 0.01 64.42 MONOCYTE COUNT INCREASED | 1 0.01 64.43 MONOCYTE PERCENTAGE INCREASED | 2 0.02 64.45 MONOPARESIS | 2 0.02 64.47 MOOD ALTERED | 4 0.04 64.51 MOOD SWINGS | 7 0.07 64.58 MORBID THOUGHTS | 2 0.02 64.60 MOTION SICKNESS | 1 0.01 64.61 MOTOR DYSFUNCTION | 3 0.03 64.64 MOUTH HAEMORRHAGE | 1 0.01 64.65 MOUTH INJURY | 2 0.02 64.67 MOUTH ULCERATION | 4 0.04 64.71 MOVEMENT DISORDER | 1 0.01 64.72 MUCOSAL EROSION | 2 0.02 64.74 MUCOSAL INFLAMMATION | 6 0.06 64.80 MUCOSAL ULCERATION | 1 0.01 64.81 MUCOUS MEMBRANE DISORDER | 1 0.01 64.82 MULTI-ORGAN DISORDER | 15 0.15 64.97 MULTI-ORGAN FAILURE | 22 0.22 65.19 MULTIPLE ALLERGIES | 2 0.02 65.21 MULTIPLE DRUG OVERDOSE | 6 0.06 65.27 MULTIPLE MYELOMA | 5 0.05 65.32 MULTIPLE SCLEROSIS | 5 0.05 65.37 MULTIPLE SCLEROSIS RELAPSE | 1 0.01 65.38 MURDER | 2 0.02 65.40 MUSCLE ATROPHY | 8 0.08 65.48 MUSCLE CONTRACTIONS INVOLUNTARY | 2 0.02 65.50 MUSCLE CONTRACTURE | 2 0.02 65.52 MUSCLE DISORDER | 2 0.02 65.54 MUSCLE ENZYME INCREASED | 1 0.01 65.55 MUSCLE FATIGUE | 1 0.01 65.56 MUSCLE INJURY | 3 0.03 65.59 MUSCLE NECROSIS | 1 0.01 65.60 MUSCLE RIGIDITY | 5 0.05 65.65 MUSCLE RUPTURE | 1 0.01 65.66 MUSCLE SPASMS | 27 0.27 65.93 MUSCLE SPASTICITY | 1 0.01 65.94 MUSCLE STRAIN | 3 0.03 65.97 MUSCLE TIGHTNESS | 3 0.03 66.00 MUSCLE TWITCHING | 8 0.08 66.08 MUSCULAR WEAKNESS | 16 0.16 66.24 MUSCULOSKELETAL CHEST PAIN | 1 0.01 66.25 MUSCULOSKELETAL PAIN | 1 0.01 66.26 MUSCULOSKELETAL STIFFNESS | 8 0.08 66.34 MYALGIA | 34 0.34 66.68 MYASTHENIA GRAVIS | 1 0.01 66.69 MYCOBACTERIUM AVIUM COMPLEX IMMUNE RE.. | 1 0.01 66.70 MYCOBACTERIUM MARINUM INFECTION | 1 0.01 66.71 MYCOPLASMA INFECTION | 1 0.01 66.72 MYCOSIS FUNGOIDES | 2 0.02 66.74 MYDRIASIS | 3 0.03 66.77 MYELITIS | 1 0.01 66.78 MYELITIS TRANSVERSE | 1 0.01 66.79 MYELODYSPLASTIC SYNDROME | 2 0.02 66.81 MYELOFIBROSIS | 1 0.01 66.82 MYOCARDIAL FIBROSIS | 1 0.01 66.83 MYOCARDIAL INFARCTION | 127 1.27 68.10 MYOCARDIAL ISCHAEMIA | 8 0.08 68.18 MYOCARDIAL RUPTURE | 1 0.01 68.19 MYOCLONUS | 3 0.03 68.22 MYOFASCIAL PAIN SYNDROME | 1 0.01 68.23 MYOGLOBIN BLOOD INCREASED | 2 0.02 68.25 MYOGLOBIN URINE PRESENT | 1 0.01 68.26 MYOPATHY | 2 0.02 68.28 MYOPIA | 1 0.01 68.29 MYOSITIS | 2 0.02 68.31 MYOSITIS-LIKE SYNDROME | 1 0.01 68.32 NAIL DISORDER | 2 0.02 68.34 NARCOLEPSY | 2 0.02 68.36 NASAL CONGESTION | 2 0.02 68.38 NASAL POLYPS | 1 0.01 68.39 NASAL SEPTUM DEVIATION | 2 0.02 68.41 NASAL ULCER | 1 0.01 68.42 NASOPHARYNGEAL DISORDER | 1 0.01 68.43 NASOPHARYNGEAL REFLUX | 1 0.01 68.44 NASOPHARYNGITIS | 7 0.07 68.51 NAUSEA | 100 1.00 69.51 NECK PAIN | 8 0.08 69.59 NECROSIS | 6 0.06 69.65 NECROTISING FASCIITIS | 1 0.01 69.66 NEONATAL APNOEIC ATTACK | 2 0.02 69.68 NEONATAL DISORDER | 5 0.05 69.73 NEONATAL HEPATOMEGALY | 1 0.01 69.74 NEONATAL RESPIRATORY DISTRESS SYNDROME | 2 0.02 69.76 NEOPLASM | 3 0.03 69.79 NEOPLASM MALIGNANT | 6 0.06 69.85 NEOPLASM PROGRESSION | 2 0.02 69.87 NEOPLASM SKIN | 1 0.01 69.88 NEPHRITIS INTERSTITIAL | 2 0.02 69.90 NEPHROGENIC DIABETES INSIPIDUS | 1 0.01 69.91 NEPHROLITHIASIS | 6 0.06 69.97 NEPHROPATHY TOXIC | 1 0.01 69.98 NEPHROTIC SYNDROME | 3 0.03 70.01 NERVE DEGENERATION | 1 0.01 70.02 NERVE INJURY | 1 0.01 70.03 NERVOUS SYSTEM DISORDER | 5 0.05 70.08 NERVOUSNESS | 14 0.14 70.22 NEURALGIA | 2 0.02 70.24 NEUROBORRELIOSIS | 1 0.01 70.25 NEUROGENIC BLADDER | 2 0.02 70.27 NEUROLEPTIC MALIGNANT SYNDROME | 7 0.07 70.34 NEUROLOGICAL SYMPTOM | 2 0.02 70.36 NEUROPATHIC PAIN | 2 0.02 70.38 NEUROPATHY | 3 0.03 70.41 NEUROPATHY PERIPHERAL | 12 0.12 70.53 NEUROSIS | 1 0.01 70.54 NEUROTOXICITY | 3 0.03 70.57 NEUTROPENIA | 31 0.31 70.88 NEUTROPENIA NEONATAL | 2 0.02 70.90 NEUTROPENIC COLITIS | 1 0.01 70.91 NEUTROPENIC INFECTION | 1 0.01 70.92 NEUTROPENIC SEPSIS | 2 0.02 70.94 NEUTROPHIL COUNT DECREASED | 7 0.07 71.01 NEUTROPHIL COUNT INCREASED | 3 0.03 71.04 NEUTROPHIL PERCENTAGE DECREASED | 2 0.02 71.06 NEUTROPHIL PERCENTAGE INCREASED | 2 0.02 71.08 NEUTROPHILIA | 2 0.02 71.10 NIGHT SWEATS | 5 0.05 71.15 NIGHTMARE | 3 0.03 71.18 NIPPLE PAIN | 1 0.01 71.19 NITRITE URINE PRESENT | 2 0.02 71.21 NO ADVERSE EFFECT | 3 0.03 71.24 NO THERAPEUTIC RESPONSE | 1 0.01 71.25 NOCARDIOSIS | 1 0.01 71.26 NOCTURIA | 1 0.01 71.27 NODULE | 1 0.01 71.28 NON-CARDIAC CHEST PAIN | 3 0.03 71.31 NON-HODGKIN'S LYMPHOMA | 1 0.01 71.32 NON-SMALL CELL LUNG CANCER | 1 0.01 71.33 NORMAL NEWBORN | 1 0.01 71.34 NORMAL PRESSURE HYDROCEPHALUS | 2 0.02 71.36 NYSTAGMUS | 3 0.03 71.39 OBESITY | 3 0.03 71.42 OBLITERATIVE BRONCHIOLITIS | 3 0.03 71.45 OBSESSIVE THOUGHTS | 1 0.01 71.46 OBSESSIVE-COMPULSIVE DISORDER | 3 0.03 71.49 OBSTRUCTION | 2 0.02 71.51 OBSTRUCTIVE AIRWAYS DISORDER | 3 0.03 71.54 OCCULT BLOOD POSITIVE | 1 0.01 71.55 OCULAR HYPERAEMIA | 1 0.01 71.56 OCULAR ICTERUS | 5 0.05 71.61 OCULAR VASCULAR DISORDER | 1 0.01 71.62 OCULOMUCOCUTANEOUS SYNDROME | 1 0.01 71.63 ODYNOPHAGIA | 1 0.01 71.64 OEDEMA | 11 0.11 71.75 OEDEMA MOUTH | 1 0.01 71.76 OEDEMA MUCOSAL | 3 0.03 71.79 OEDEMA PERIPHERAL | 35 0.35 72.14 OESOPHAGEAL ATRESIA | 2 0.02 72.16 OESOPHAGEAL CANCER METASTATIC | 1 0.01 72.17 OESOPHAGEAL CANDIDIASIS | 1 0.01 72.18 OESOPHAGEAL CARCINOMA | 1 0.01 72.19 OESOPHAGEAL DISORDER | 1 0.01 72.20 OESOPHAGEAL SPASM | 1 0.01 72.21 OESOPHAGEAL ULCER | 2 0.02 72.23 OESOPHAGITIS | 4 0.04 72.27 OESTROGEN RECEPTOR ASSAY POSITIVE | 1 0.01 72.28 OFF LABEL USE | 1 0.01 72.29 OLIGURIA | 3 0.03 72.32 ONYCHOMYCOSIS | 1 0.01 72.33 OPEN WOUND | 3 0.03 72.36 OPPORTUNISTIC INFECTION | 1 0.01 72.37 OPTIC ATROPHY | 1 0.01 72.38 OPTIC ISCHAEMIC NEUROPATHY | 3 0.03 72.41 OPTIC NERVE DISORDER | 1 0.01 72.42 OPTIC NERVE INJURY | 1 0.01 72.43 OPTIC NEURITIS | 1 0.01 72.44 OPTIC NEURITIS RETROBULBAR | 1 0.01 72.45 OPTIC NEUROPATHY | 3 0.03 72.48 ORAL CANDIDIASIS | 2 0.02 72.50 ORAL DISCOMFORT | 1 0.01 72.51 ORAL FUNGAL INFECTION | 3 0.03 72.54 ORAL INFECTION | 1 0.01 72.55 ORAL INTAKE REDUCED | 8 0.08 72.63 ORAL MUCOSAL BLISTERING | 1 0.01 72.64 ORAL MUCOSAL DISORDER | 2 0.02 72.66 ORAL PAIN | 6 0.06 72.72 ORAL SOFT TISSUE DISORDER | 2 0.02 72.74 ORAL SURGERY | 2 0.02 72.76 ORGASM ABNORMAL | 1 0.01 72.77 ORTHOSTATIC HYPOTENSION | 4 0.04 72.81 OSTECTOMY | 1 0.01 72.82 OSTEITIS | 1 0.01 72.83 OSTEOARTHRITIS | 12 0.12 72.95 OSTEOLYSIS | 2 0.02 72.97 OSTEOMYELITIS | 8 0.08 73.05 OSTEONECROSIS | 5 0.05 73.10 OSTEOPENIA | 4 0.04 73.14 OSTEOPOROSIS | 1 0.01 73.15 OSTEOSCLEROSIS | 1 0.01 73.16 OSTEOSYNTHESIS | 1 0.01 73.17 OTITIS MEDIA | 2 0.02 73.19 OTORRHOEA | 1 0.01 73.20 OTOTOXICITY | 1 0.01 73.21 OVARIAN CANCER | 1 0.01 73.22 OVARIAN CYST RUPTURED | 1 0.01 73.23 OVARIAN FIBROSIS | 1 0.01 73.24 OVARIAN NEOPLASM | 1 0.01 73.25 OVERDOSE | 35 0.35 73.60 OXYGEN SATURATION DECREASED | 14 0.14 73.74 PAEDOPHILIA | 1 0.01 73.75 PAIN | 50 0.50 74.25 PAIN IN EXTREMITY | 30 0.30 74.55 PAIN IN JAW | 3 0.03 74.58 PAINFUL RESPIRATION | 2 0.02 74.60 PALATAL DISORDER | 1 0.01 74.61 PALLOR | 2 0.02 74.63 PALPITATIONS | 17 0.17 74.80 PANCREAS INFECTION | 1 0.01 74.81 PANCREATIC CARCINOMA | 1 0.01 74.82 PANCREATIC CARCINOMA METASTATIC | 1 0.01 74.83 PANCREATIC HAEMORRHAGE | 2 0.02 74.85 PANCREATIC INJURY | 1 0.01 74.86 PANCREATIC NECROSIS | 1 0.01 74.87 PANCREATITIS | 6 0.06 74.93 PANCREATITIS ACUTE | 5 0.05 74.98 PANCREATITIS CHRONIC | 2 0.02 75.00 PANCYTOPENIA | 17 0.17 75.17 PANIC ATTACK | 4 0.04 75.21 PANIC DISORDER | 1 0.01 75.22 PANIC REACTION | 3 0.03 75.25 PAPILLARY THYROID CANCER | 1 0.01 75.26 PAPILLOEDEMA | 3 0.03 75.29 PAPILLOMA | 1 0.01 75.30 PARAESTHESIA | 21 0.21 75.51 PARAESTHESIA MUCOSAL | 1 0.01 75.52 PARAESTHESIA ORAL | 1 0.01 75.53 PARAINFLUENZAE VIRUS INFECTION | 1 0.01 75.54 PARALYSIS | 8 0.08 75.62 PARANEOPLASTIC SYNDROME | 1 0.01 75.63 PARANOIA | 4 0.04 75.67 PARAPARESIS | 1 0.01 75.68 PARAPLEGIA | 2 0.02 75.70 PARESIS | 2 0.02 75.72 PARKINSON'S DISEASE | 6 0.06 75.78 PARKINSONISM | 2 0.02 75.80 PAROSMIA | 1 0.01 75.81 PAROTITIS | 1 0.01 75.82 PATENT DUCTUS ARTERIOSUS | 1 0.01 75.83 PATHOGEN RESISTANCE | 1 0.01 75.84 PATHOLOGICAL FRACTURE | 3 0.03 75.87 PATHOLOGICAL GAMBLING | 1 0.01 75.88 PCO2 INCREASED | 1 0.01 75.89 PEAU D'ORANGE | 1 0.01 75.90 PELVIC PAIN | 1 0.01 75.91 PEMPHIGUS | 1 0.01 75.92 PEPTIC ULCER | 2 0.02 75.94 PEPTIC ULCER HAEMORRHAGE | 1 0.01 75.95 PERFORMANCE STATUS DECREASED | 1 0.01 75.96 PERIARTHRITIS | 1 0.01 75.97 PERICARDIAL EFFUSION | 5 0.05 76.02 PERICARDIAL HAEMORRHAGE | 2 0.02 76.04 PERICARDITIS | 2 0.02 76.06 PERIODONTITIS | 2 0.02 76.08 PERIORBITAL DISORDER | 1 0.01 76.09 PERIORBITAL OEDEMA | 3 0.03 76.12 PERIPHERAL CIRCULATORY FAILURE | 1 0.01 76.13 PERIPHERAL COLDNESS | 2 0.02 76.15 PERIPHERAL EMBOLISM | 2 0.02 76.17 PERIPHERAL ISCHAEMIA | 1 0.01 76.18 PERIPHERAL OCCLUSIVE DISEASE | 2 0.02 76.20 PERIPHERAL VASCULAR DISORDER | 2 0.02 76.22 PERIRENAL HAEMATOMA | 1 0.01 76.23 PERITONEAL DIALYSIS | 1 0.01 76.24 PERITONEAL TUBERCULOSIS | 1 0.01 76.25 PERITONITIS | 6 0.06 76.31 PERITONSILLAR ABSCESS | 1 0.01 76.32 PERONEAL NERVE PALSY | 2 0.02 76.34 PERSONALITY CHANGE | 2 0.02 76.36 PETECHIAE | 5 0.05 76.41 PETIT MAL EPILEPSY | 2 0.02 76.43 PHARMACEUTICAL PRODUCT COMPLAINT | 31 0.31 76.74 PHARYNGEAL HAEMORRHAGE | 1 0.01 76.75 PHARYNGEAL OEDEMA | 1 0.01 76.76 PHARYNGITIS | 1 0.01 76.77 PHARYNGITIS STREPTOCOCCAL | 4 0.04 76.81 PHARYNGOLARYNGEAL PAIN | 9 0.09 76.90 PHIMOSIS | 1 0.01 76.91 PHLEBITIS | 3 0.03 76.94 PHOTOPHOBIA | 6 0.06 77.00 PHOTOPSIA | 1 0.01 77.01 PHOTOSENSITIVITY REACTION | 3 0.03 77.04 PHYSICAL ASSAULT | 1 0.01 77.05 PICKWICKIAN SYNDROME | 1 0.01 77.06 PIGMENTATION DISORDER | 3 0.03 77.09 PILONIDAL CYST | 1 0.01 77.10 PITUITARY TUMOUR BENIGN | 1 0.01 77.11 PITUITARY-DEPENDENT CUSHING'S SYNDROME | 1 0.01 77.12 PITYRIASIS RUBRA PILARIS | 1 0.01 77.13 PLANTAR FASCIITIS | 1 0.01 77.14 PLASMAPHERESIS | 1 0.01 77.15 PLATELET COUNT DECREASED | 24 0.24 77.39 PLATELET COUNT INCREASED | 5 0.05 77.44 PLATELET DISORDER | 1 0.01 77.45 PLEURAL DISORDER | 1 0.01 77.46 PLEURAL EFFUSION | 15 0.15 77.61 PLEURAL INFECTION | 1 0.01 77.62 PLEURISY | 4 0.04 77.66 PLEURITIC PAIN | 1 0.01 77.67 PLEUROTHOTONUS | 1 0.01 77.68 PNEUMATOSIS INTESTINALIS | 1 0.01 77.69 PNEUMOCOCCAL SEPSIS | 1 0.01 77.70 PNEUMOCYSTIS JIROVECI INFECTION | 2 0.02 77.72 PNEUMOCYSTIS JIROVECI PNEUMONIA | 7 0.07 77.79 PNEUMONIA | 51 0.51 78.30 PNEUMONIA ASPIRATION | 6 0.06 78.36 PNEUMONIA BACTERIAL | 1 0.01 78.37 PNEUMONIA FUNGAL | 1 0.01 78.38 PNEUMONIA LEGIONELLA | 1 0.01 78.39 PNEUMONIA PRIMARY ATYPICAL | 1 0.01 78.40 PNEUMONITIS | 6 0.06 78.46 PNEUMOPERITONEUM | 1 0.01 78.47 PNEUMOTHORAX | 4 0.04 78.51 PO2 DECREASED | 1 0.01 78.52 POISONING | 2 0.02 78.54 POLLAKIURIA | 10 0.10 78.64 POLYCYTHAEMIA | 1 0.01 78.65 POLYCYTHAEMIA VERA | 1 0.01 78.66 POLYDIPSIA | 3 0.03 78.69 POLYNEUROPATHY | 4 0.04 78.73 POLYP | 2 0.02 78.75 POLYP COLORECTAL | 1 0.01 78.76 POLYSUBSTANCE ABUSE | 6 0.06 78.82 POLYTRAUMATISM | 6 0.06 78.88 POLYURIA | 3 0.03 78.91 POOR PERIPHERAL CIRCULATION | 1 0.01 78.92 POOR QUALITY DRUG ADMINISTERED | 1 0.01 78.93 POOR SUCKING REFLEX | 2 0.02 78.95 PORTAL VEIN THROMBOSIS | 1 0.01 78.96 POST HERPETIC NEURALGIA | 1 0.01 78.97 POST PROCEDURAL COMPLICATION | 13 0.13 79.10 POST PROCEDURAL HAEMORRHAGE | 4 0.04 79.14 POST PROCEDURAL URINE LEAK | 1 0.01 79.15 POST THROMBOTIC SYNDROME | 2 0.02 79.17 POST-TRAUMATIC OSTEOPOROSIS | 1 0.01 79.18 POST-TRAUMATIC STRESS DISORDER | 4 0.04 79.22 POSTICTAL STATE | 1 0.01 79.23 POSTMENOPAUSAL HAEMORRHAGE | 1 0.01 79.24 POSTNASAL DRIP | 1 0.01 79.25 POSTOPERATIVE INFECTION | 1 0.01 79.26 POVERTY OF SPEECH | 1 0.01 79.27 PRE-ECLAMPSIA | 1 0.01 79.28 PRECANCEROUS CELLS PRESENT | 1 0.01 79.29 PREGNANCY | 9 0.09 79.38 PREGNANCY OF PARTNER | 1 0.01 79.39 PREGNANCY ON ORAL CONTRACEPTIVE | 2 0.02 79.41 PREGNANCY WITH INJECTABLE CONTRACEPTIVE | 1 0.01 79.42 PREMATURE BABY | 6 0.06 79.48 PREMATURE LABOUR | 5 0.05 79.53 PRESCRIBED OVERDOSE | 4 0.04 79.57 PRIMARY SEQUESTRUM | 1 0.01 79.58 PROCEDURAL COMPLICATION | 6 0.06 79.64 PROCEDURAL PAIN | 3 0.03 79.67 PROCEDURAL SITE REACTION | 1 0.01 79.68 PROCTALGIA | 2 0.02 79.70 PROCTITIS | 1 0.01 79.71 PRODUCTIVE COUGH | 7 0.07 79.78 PROGESTERONE RECEPTOR ASSAY POSITIVE | 1 0.01 79.79 PROSTATE CANCER | 1 0.01 79.80 PROSTATIC SPECIFIC ANTIGEN INCREASED | 2 0.02 79.82 PROSTHESIS USER | 1 0.01 79.83 PROTEIN TOTAL INCREASED | 1 0.01 79.84 PROTEIN URINE PRESENT | 3 0.03 79.87 PROTEINURIA | 6 0.06 79.93 PROTHROMBIN LEVEL DECREASED | 3 0.03 79.96 PROTHROMBIN TIME PROLONGED | 6 0.06 80.02 PROTHROMBIN TIME RATIO ABNORMAL | 1 0.01 80.03 PROTHROMBIN TIME SHORTENED | 1 0.01 80.04 PRURIGO | 1 0.01 80.05 PRURITUS | 31 0.31 80.36 PRURITUS ANI | 1 0.01 80.37 PRURITUS GENERALISED | 1 0.01 80.38 PSEUDOBULBAR PALSY | 1 0.01 80.39 PSEUDOCYST | 1 0.01 80.40 PSEUDOMONAL SEPSIS | 2 0.02 80.42 PSEUDOMONAS INFECTION | 3 0.03 80.45 PSORIASIS | 7 0.07 80.52 PSYCHIATRIC SYMPTOM | 1 0.01 80.53 PSYCHOMOTOR HYPERACTIVITY | 6 0.06 80.59 PSYCHOMOTOR RETARDATION | 1 0.01 80.60 PSYCHOMOTOR SKILLS IMPAIRED | 1 0.01 80.61 PSYCHOTIC DISORDER | 8 0.08 80.69 PULMONARY ALVEOLAR HAEMORRHAGE | 1 0.01 80.70 PULMONARY CONGESTION | 1 0.01 80.71 PULMONARY EMBOLISM | 27 0.27 80.98 PULMONARY EOSINOPHILIA | 1 0.01 80.99 PULMONARY FIBROSIS | 8 0.08 81.07 PULMONARY FUNCTION TEST DECREASED | 1 0.01 81.08 PULMONARY HAEMORRHAGE | 2 0.02 81.10 PULMONARY HYPERTENSION | 3 0.03 81.13 PULMONARY INFARCTION | 1 0.01 81.14 PULMONARY MASS | 1 0.01 81.15 PULMONARY OEDEMA | 15 0.15 81.30 PULMONARY THROMBOSIS | 1 0.01 81.31 PULMONARY TOXICITY | 1 0.01 81.32 PULMONARY TUBERCULOSIS | 3 0.03 81.35 PULSE ABSENT | 2 0.02 81.37 PULSE PRESSURE INCREASED | 1 0.01 81.38 PURPURA | 5 0.05 81.43 PURULENT DISCHARGE | 4 0.04 81.47 PUSTULAR PSORIASIS | 1 0.01 81.48 PYELONEPHRITIS | 1 0.01 81.49 PYELONEPHRITIS ACUTE | 1 0.01 81.50 PYLORIC STENOSIS | 1 0.01 81.51 PYODERMA GANGRENOSUM | 2 0.02 81.53 PYOGENIC GRANULOMA | 1 0.01 81.54 PYREXIA | 84 0.84 82.38 QRS AXIS ABNORMAL | 1 0.01 82.39 QUADRIPARESIS | 1 0.01 82.40 RADIATION INJURY | 2 0.02 82.42 RADICULITIS | 1 0.01 82.43 RADICULOPATHY | 1 0.01 82.44 RALES | 2 0.02 82.46 RASH | 44 0.44 82.90 RASH ERYTHEMATOUS | 9 0.09 82.99 RASH GENERALISED | 9 0.09 83.08 RASH MACULAR | 6 0.06 83.14 RASH MACULO-PAPULAR | 4 0.04 83.18 RASH PAPULAR | 5 0.05 83.23 RASH PRURITIC | 2 0.02 83.25 RASH PUSTULAR | 8 0.08 83.33 RASH VESICULAR | 2 0.02 83.35 RAYNAUD'S PHENOMENON | 1 0.01 83.36 READING DISORDER | 1 0.01 83.37 REBOUND EFFECT | 1 0.01 83.38 RECTAL HAEMORRHAGE | 27 0.27 83.65 RED BLOOD CELL COUNT DECREASED | 5 0.05 83.70 RED BLOOD CELL SEDIMENTATION RATE INC.. | 7 0.07 83.77 REFLUX OESOPHAGITIS | 2 0.02 83.79 REFUSAL OF TREATMENT BY PATIENT | 5 0.05 83.84 REGURGITATION OF FOOD | 1 0.01 83.85 REITER'S SYNDROME | 1 0.01 83.86 RENAL ARTERY FIBROMUSCULAR DYSPLASIA | 1 0.01 83.87 RENAL ARTERY STENOSIS | 1 0.01 83.88 RENAL CELL CARCINOMA STAGE UNSPECIFIED | 2 0.02 83.90 RENAL CYST | 6 0.06 83.96 RENAL DISORDER | 13 0.13 84.09 RENAL FAILURE | 38 0.38 84.47 RENAL FAILURE ACUTE | 45 0.45 84.92 RENAL FAILURE CHRONIC | 5 0.05 84.97 RENAL IMPAIRMENT | 14 0.14 85.11 RENAL INFARCT | 2 0.02 85.13 RENAL INTERSTITIAL FIBROSIS | 1 0.01 85.14 RENAL ISCHAEMIA | 1 0.01 85.15 RENAL PAIN | 4 0.04 85.19 RENAL TUBULAR DISORDER | 1 0.01 85.20 RENAL TUBULAR NECROSIS | 5 0.05 85.25 RENAL VEIN THROMBOSIS | 1 0.01 85.26 RENOVASCULAR HYPERTENSION | 1 0.01 85.27 RESPIRATION ABNORMAL | 1 0.01 85.28 RESPIRATORY ACIDOSIS | 1 0.01 85.29 RESPIRATORY ALKALOSIS | 1 0.01 85.30 RESPIRATORY ARREST | 7 0.07 85.37 RESPIRATORY DEPRESSION | 1 0.01 85.38 RESPIRATORY DISORDER | 4 0.04 85.42 RESPIRATORY DISORDER NEONATAL | 1 0.01 85.43 RESPIRATORY DISTRESS | 11 0.11 85.54 RESPIRATORY FAILURE | 21 0.21 85.75 RESPIRATORY RATE DECREASED | 1 0.01 85.76 RESPIRATORY RATE INCREASED | 6 0.06 85.82 RESPIRATORY TRACT INFECTION | 6 0.06 85.88 RESPIRATORY TRACT INFECTION VIRAL | 1 0.01 85.89 RESTLESS LEGS SYNDROME | 2 0.02 85.91 RESTLESSNESS | 6 0.06 85.97 RESUSCITATION | 1 0.01 85.98 RETCHING | 6 0.06 86.04 RETICULOCYTE COUNT INCREASED | 1 0.01 86.05 RETINAL DEGENERATION | 1 0.01 86.06 RETINAL HAEMORRHAGE | 2 0.02 86.08 RETINAL PIGMENTATION | 1 0.01 86.09 RETINAL VASCULAR DISORDER | 1 0.01 86.10 RETINAL VEIN OCCLUSION | 2 0.02 86.12 RETINAL VEIN THROMBOSIS | 2 0.02 86.14 RETINOPATHY HYPERTENSIVE | 1 0.01 86.15 RETROPERITONEAL FIBROSIS | 1 0.01 86.16 RHABDOMYOLYSIS | 16 0.16 86.32 RHEUMATOID ARTHRITIS | 6 0.06 86.38 RHEUMATOID LUNG | 1 0.01 86.39 RHINITIS | 1 0.01 86.40 RHINORRHOEA | 3 0.03 86.43 RHONCHI | 1 0.01 86.44 RIB FRACTURE | 2 0.02 86.46 RIGHT VENTRICULAR FAILURE | 1 0.01 86.47 RIGHT VENTRICULAR SYSTOLIC PRESSURE I.. | 1 0.01 86.48 ROAD TRAFFIC ACCIDENT | 8 0.08 86.56 ROSACEA | 1 0.01 86.57 ROTATOR CUFF SYNDROME | 3 0.03 86.60 SACROILIITIS | 2 0.02 86.62 SALIVARY HYPERSECRETION | 3 0.03 86.65 SALMONELLOSIS | 1 0.01 86.66 SAPHO SYNDROME | 1 0.01 86.67 SARCOIDOSIS | 3 0.03 86.70 SCAB | 1 0.01 86.71 SCAR | 4 0.04 86.75 SCHIZOAFFECTIVE DISORDER | 1 0.01 86.76 SCHIZOPHRENIA | 2 0.02 86.78 SCHIZOPHRENIA, PARANOID TYPE | 1 0.01 86.79 SCHIZOPHRENIFORM DISORDER | 1 0.01 86.80 SCIATIC NERVE INJURY | 1 0.01 86.81 SCIATICA | 1 0.01 86.82 SCLERITIS | 1 0.01 86.83 SCLERODERMA | 6 0.06 86.89 SCOLIOSIS | 1 0.01 86.90 SCOTOMA | 1 0.01 86.91 SCRATCH | 1 0.01 86.92 SEASONAL ALLERGY | 1 0.01 86.93 SEBORRHOEIC DERMATITIS | 1 0.01 86.94 SEDATION | 6 0.06 87.00 SELF INJURIOUS BEHAVIOUR | 2 0.02 87.02 SELF-INJURIOUS IDEATION | 1 0.01 87.03 SELF-MEDICATION | 4 0.04 87.07 SENSATION OF FOREIGN BODY | 2 0.02 87.09 SENSE OF OPPRESSION | 1 0.01 87.10 SENSITIVITY OF TEETH | 1 0.01 87.11 SENSORY DISTURBANCE | 2 0.02 87.13 SENSORY LOSS | 2 0.02 87.15 SEPSIS | 29 0.29 87.44 SEPTIC EMBOLUS | 1 0.01 87.45 SEPTIC SHOCK | 6 0.06 87.51 SEROSITIS | 1 0.01 87.52 SEROTONIN SYNDROME | 3 0.03 87.55 SERUM FERRITIN INCREASED | 4 0.04 87.59 SEXUAL ASSAULT VICTIM | 1 0.01 87.60 SEXUAL DYSFUNCTION | 2 0.02 87.62 SHIFT TO THE LEFT | 1 0.01 87.63 SHOCK | 10 0.10 87.73 SHOCK HAEMORRHAGIC | 2 0.02 87.75 SHOULDER PAIN | 4 0.04 87.79 SICCA SYNDROME | 1 0.01 87.80 SICK SINUS SYNDROME | 3 0.03 87.83 SIDEROBLASTIC ANAEMIA | 2 0.02 87.85 SILENT MYOCARDIAL INFARCTION | 1 0.01 87.86 SIMPLE PARTIAL SEIZURES | 1 0.01 87.87 SINOATRIAL BLOCK | 2 0.02 87.89 SINUS ARREST | 2 0.02 87.91 SINUS ARRHYTHMIA | 3 0.03 87.94 SINUS BRADYCARDIA | 5 0.05 87.99 SINUS CONGESTION | 1 0.01 88.00 SINUS DISORDER | 2 0.02 88.02 SINUS TACHYCARDIA | 6 0.06 88.08 SINUSITIS | 9 0.09 88.17 SJOGREN'S SYNDROME | 1 0.01 88.18 SKIN CANCER | 2 0.02 88.20 SKIN DISCOLOURATION | 2 0.02 88.22 SKIN DISORDER | 6 0.06 88.28 SKIN EXFOLIATION | 4 0.04 88.32 SKIN FISSURES | 1 0.01 88.33 SKIN HAEMORRHAGE | 1 0.01 88.34 SKIN HYPERPIGMENTATION | 4 0.04 88.38 SKIN IRRITATION | 1 0.01 88.39 SKIN LACERATION | 2 0.02 88.41 SKIN LESION | 4 0.04 88.45 SKIN NECROSIS | 1 0.01 88.46 SKIN OEDEMA | 1 0.01 88.47 SKIN REACTION | 1 0.01 88.48 SKIN TEST POSITIVE | 4 0.04 88.52 SKIN ULCER | 7 0.07 88.59 SLEEP APNOEA SYNDROME | 3 0.03 88.62 SLEEP DISORDER | 4 0.04 88.66 SLEEP TERROR | 1 0.01 88.67 SLEEP WALKING | 1 0.01 88.68 SMALL FOR DATES BABY | 1 0.01 88.69 SMALL INTESTINAL HAEMORRHAGE | 1 0.01 88.70 SMALL INTESTINAL OBSTRUCTION | 4 0.04 88.74 SMEAR CERVIX ABNORMAL | 1 0.01 88.75 SMOKER | 1 0.01 88.76 SOCIAL AVOIDANT BEHAVIOUR | 5 0.05 88.81 SOFT TISSUE HAEMORRHAGE | 1 0.01 88.82 SOMNOLENCE | 31 0.31 89.13 SOPOR | 1 0.01 89.14 SPEECH DISORDER | 9 0.09 89.23 SPEECH DISORDER DEVELOPMENTAL | 4 0.04 89.27 SPERM COUNT DECREASED | 1 0.01 89.28 SPINAL COLUMN STENOSIS | 1 0.01 89.29 SPINAL DISORDER | 2 0.02 89.31 SPINAL FRACTURE | 2 0.02 89.33 SPINAL FUSION SURGERY | 1 0.01 89.34 SPINAL OSTEOARTHRITIS | 6 0.06 89.40 SPLEEN DISORDER | 1 0.01 89.41 SPLEEN TUBERCULOSIS | 1 0.01 89.42 SPLENIC ABSCESS | 1 0.01 89.43 SPLENIC RUPTURE | 1 0.01 89.44 SPLENITIS | 1 0.01 89.45 SPLENOMEGALY | 2 0.02 89.47 SPLINTER HAEMORRHAGES | 1 0.01 89.48 SPONDYLOLISTHESIS | 2 0.02 89.50 SPOUSAL ABUSE | 1 0.01 89.51 SPUTUM CULTURE POSITIVE | 1 0.01 89.52 SPUTUM DISCOLOURED | 1 0.01 89.53 SPUTUM PURULENT | 1 0.01 89.54 SQUAMOUS CELL CARCINOMA | 1 0.01 89.55 STAPHYLOCOCCAL ABSCESS | 1 0.01 89.56 STAPHYLOCOCCAL BACTERAEMIA | 2 0.02 89.58 STAPHYLOCOCCAL INFECTION | 12 0.12 89.70 STAPHYLOCOCCAL SEPSIS | 3 0.03 89.73 STASIS DERMATITIS | 1 0.01 89.74 STATUS EPILEPTICUS | 2 0.02 89.76 STENT OCCLUSION | 2 0.02 89.78 STEVENS-JOHNSON SYNDROME | 9 0.09 89.87 STILLBIRTH | 2 0.02 89.89 STITCH ABSCESS | 1 0.01 89.90 STOMACH DISCOMFORT | 3 0.03 89.93 STOMATITIS | 8 0.08 90.01 STOOL ANALYSIS ABNORMAL | 1 0.01 90.02 STRABISMUS | 3 0.03 90.05 STREPTOCOCCAL SEROLOGY POSITIVE | 1 0.01 90.06 STRESS | 8 0.08 90.14 STRESS FRACTURE | 1 0.01 90.15 STRIDOR | 3 0.03 90.18 STRONGYLOIDIASIS | 2 0.02 90.20 STUPOR | 1 0.01 90.21 SUBARACHNOID HAEMORRHAGE | 1 0.01 90.22 SUBDURAL HAEMATOMA | 3 0.03 90.25 SUDDEN CARDIAC DEATH | 3 0.03 90.28 SUDDEN DEATH | 7 0.07 90.35 SUDDEN HEARING LOSS | 1 0.01 90.36 SUDDEN ONSET OF SLEEP | 1 0.01 90.37 SUFFOCATION FEELING | 1 0.01 90.38 SUICIDAL IDEATION | 33 0.33 90.71 SUICIDE ATTEMPT | 26 0.26 90.97 SUPRAVENTRICULAR EXTRASYSTOLES | 2 0.02 90.99 SUPRAVENTRICULAR TACHYCARDIA | 4 0.04 91.03 SURGERY | 11 0.11 91.14 SUTURE INSERTION | 2 0.02 91.16 SWEAT GLAND DISORDER | 1 0.01 91.17 SWELLING | 7 0.07 91.24 SWELLING FACE | 9 0.09 91.33 SWOLLEN TONGUE | 4 0.04 91.37 SYMBLEPHARON | 2 0.02 91.39 SYNCOPE | 26 0.26 91.65 SYNCOPE VASOVAGAL | 4 0.04 91.69 SYSTEMIC CANDIDA | 1 0.01 91.70 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME | 2 0.02 91.72 SYSTEMIC LUPUS ERYTHEMATOSUS | 5 0.05 91.77 TACHYARRHYTHMIA | 2 0.02 91.79 TACHYCARDIA | 19 0.19 91.98 TACHYPNOEA | 5 0.05 92.03 TALIPES | 1 0.01 92.04 TARDIVE DYSKINESIA | 1 0.01 92.05 TEARFULNESS | 3 0.03 92.08 TEETH BRITTLE | 1 0.01 92.09 TEMPERATURE REGULATION DISORDER | 1 0.01 92.10 TEMPORAL ARTERITIS | 3 0.03 92.13 TENDERNESS | 1 0.01 92.14 TENDON DISORDER | 4 0.04 92.18 TENDON RUPTURE | 2 0.02 92.20 TENDON SHEATH INCISION | 1 0.01 92.21 TENDONITIS | 1 0.01 92.22 TENOSYNOVITIS | 1 0.01 92.23 TENSION | 2 0.02 92.25 TENSION HEADACHE | 1 0.01 92.26 TERMINAL STATE | 1 0.01 92.27 TESTICULAR CYST | 1 0.01 92.28 TESTICULAR SWELLING | 1 0.01 92.29 TESTICULAR TORSION | 1 0.01 92.30 TESTICULAR YOLK SAC TUMOUR STAGE I | 1 0.01 92.31 TESTIS CANCER | 1 0.01 92.32 TETANY | 1 0.01 92.33 THALAMIC SYNDROME | 1 0.01 92.34 THALASSAEMIA | 1 0.01 92.35 THALASSAEMIA BETA | 1 0.01 92.36 THERAPEUTIC AGENT TOXICITY | 1 0.01 92.37 THERAPEUTIC RESPONSE DECREASED | 3 0.03 92.40 THERAPEUTIC RESPONSE UNEXPECTED WITH .. | 2 0.02 92.42 THERAPY NON-RESPONDER | 11 0.11 92.53 THERMAL BURN | 1 0.01 92.54 THINKING ABNORMAL | 3 0.03 92.57 THIRST | 2 0.02 92.59 THROAT IRRITATION | 4 0.04 92.63 THROAT TIGHTNESS | 3 0.03 92.66 THROMBOCYTHAEMIA | 1 0.01 92.67 THROMBOCYTOPENIA | 31 0.31 92.98 THROMBOCYTOPENIC PURPURA | 9 0.09 93.07 THROMBOPHLEBITIS | 1 0.01 93.08 THROMBOPHLEBITIS SUPERFICIAL | 2 0.02 93.10 THROMBOSIS | 11 0.11 93.21 THROMBOSIS IN DEVICE | 3 0.03 93.24 THROMBOTIC MICROANGIOPATHY | 3 0.03 93.27 THROMBOTIC STROKE | 3 0.03 93.30 THROMBOTIC THROMBOCYTOPENIC PURPURA | 2 0.02 93.32 THYROID NEOPLASM | 2 0.02 93.34 TIC | 2 0.02 93.36 TINEA INFECTION | 1 0.01 93.37 TINNITUS | 9 0.09 93.46 TONGUE DISORDER | 3 0.03 93.49 TONGUE PARALYSIS | 1 0.01 93.50 TONIC CONVULSION | 2 0.02 93.52 TONSILLAR HYPERTROPHY | 1 0.01 93.53 TONSILLITIS | 1 0.01 93.54 TOOTH ABSCESS | 2 0.02 93.56 TOOTH DISCOLOURATION | 1 0.01 93.57 TOOTH DISORDER | 5 0.05 93.62 TOOTH EXTRACTION | 17 0.17 93.79 TOOTH INFECTION | 1 0.01 93.80 TOOTH INJURY | 1 0.01 93.81 TOOTH LOSS | 1 0.01 93.82 TOOTHACHE | 2 0.02 93.84 TORSADE DE POINTES | 3 0.03 93.87 TORTICOLLIS | 2 0.02 93.89 TOXIC EPIDERMAL NECROLYSIS | 9 0.09 93.98 TOXIC INDUCED ENCEPHALOPATHY | 1 0.01 93.99 TOXIC NODULAR GOITRE | 1 0.01 94.00 TOXIC SKIN ERUPTION | 4 0.04 94.04 TRACHEAL OEDEMA | 1 0.01 94.05 TRACHEITIS | 2 0.02 94.07 TRACHEO-OESOPHAGEAL FISTULA | 1 0.01 94.08 TRACHEOBRONCHITIS | 2 0.02 94.10 TRACHEOSTOMY | 3 0.03 94.13 TRANSAMINASES INCREASED | 8 0.08 94.21 TRANSFUSION REACTION | 2 0.02 94.23 TRANSIENT ISCHAEMIC ATTACK | 18 0.18 94.41 TRANSMISSION OF DRUG VIA SEMEN | 2 0.02 94.43 TRANSPLANT REJECTION | 1 0.01 94.44 TRANSURETHRAL BLADDER RESECTION | 1 0.01 94.45 TRAUMATIC FRACTURE | 1 0.01 94.46 TREATMENT NONCOMPLIANCE | 6 0.06 94.52 TREMOR | 31 0.31 94.83 TRICUSPID VALVE INCOMPETENCE | 5 0.05 94.88 TRISMUS | 2 0.02 94.90 TROPONIN T INCREASED | 1 0.01 94.91 TUBERCULOSIS | 4 0.04 94.95 TUBULOINTERSTITIAL NEPHRITIS | 1 0.01 94.96 TUMOUR LYSIS SYNDROME | 1 0.01 94.97 TUMOUR NECROSIS | 2 0.02 94.99 TWIN PREGNANCY | 2 0.02 95.01 TYPE III IMMUNE COMPLEX MEDIATED REAC.. | 1 0.01 95.02 TYPE IV HYPERSENSITIVITY REACTION | 2 0.02 95.04 ULCER | 5 0.05 95.09 ULCER HAEMORRHAGE | 2 0.02 95.11 ULNAR NERVE PALSY | 1 0.01 95.12 ULTRASOUND ABDOMEN ABNORMAL | 1 0.01 95.13 UMBILICAL CORD AROUND NECK | 2 0.02 95.15 UNEMPLOYMENT | 1 0.01 95.16 UNEVALUABLE EVENT | 4 0.04 95.20 UNINTENDED PREGNANCY | 2 0.02 95.22 UNRESPONSIVE TO PAIN STIMULI | 1 0.01 95.23 UNRESPONSIVE TO VERBAL STIMULI | 3 0.03 95.26 UPPER GASTROINTESTINAL HAEMORRHAGE | 3 0.03 95.29 UPPER RESPIRATORY TRACT INFECTION | 6 0.06 95.35 URETERAL STENT INSERTION | 1 0.01 95.36 URETERIC OBSTRUCTION | 4 0.04 95.40 URETERIC STENOSIS | 1 0.01 95.41 URETHRAL STRICTURE | 1 0.01 95.42 URETHRITIS | 1 0.01 95.43 URINARY BLADDER ATROPHY | 1 0.01 95.44 URINARY INCONTINENCE | 8 0.08 95.52 URINARY RETENTION | 8 0.08 95.60 URINARY SYSTEM X-RAY | 1 0.01 95.61 URINARY TRACT INFECTION | 27 0.27 95.88 URINARY TRACT INFECTION PSEUDOMONAL | 1 0.01 95.89 URINE FLOW DECREASED | 1 0.01 95.90 URINE ODOUR ABNORMAL | 1 0.01 95.91 URINE OUTPUT DECREASED | 2 0.02 95.93 UROSEPSIS | 1 0.01 95.94 URTICARIA | 18 0.18 96.12 URTICARIA GENERALISED | 4 0.04 96.16 UTERINE CANCER | 1 0.01 96.17 UTERINE DISORDER | 1 0.01 96.18 UTERINE POLYP | 1 0.01 96.19 UVEITIS | 1 0.01 96.20 VAGINAL BURNING SENSATION | 1 0.01 96.21 VAGINAL HAEMORRHAGE | 2 0.02 96.23 VAGINAL INFECTION | 1 0.01 96.24 VAGINAL PAIN | 1 0.01 96.25 VARICELLA | 1 0.01 96.26 VARICES OESOPHAGEAL | 2 0.02 96.28 VARICOSE VEIN | 2 0.02 96.30 VASCULAR MALFORMATION PERIPHERAL | 1 0.01 96.31 VASCULAR PURPURA | 1 0.01 96.32 VASCULAR RUPTURE | 1 0.01 96.33 VASCULITIS | 5 0.05 96.38 VASCULITIS CEREBRAL | 1 0.01 96.39 VASOCONSTRICTION | 1 0.01 96.40 VASOSPASM | 1 0.01 96.41 VEIN DISORDER | 1 0.01 96.42 VENA CAVA THROMBOSIS | 1 0.01 96.43 VENOOCCLUSIVE LIVER DISEASE | 5 0.05 96.48 VENOUS INSUFFICIENCY | 3 0.03 96.51 VENOUS THROMBOSIS LIMB | 1 0.01 96.52 VENTRICULAR ARRHYTHMIA | 1 0.01 96.53 VENTRICULAR DYSFUNCTION | 5 0.05 96.58 VENTRICULAR EXTRASYSTOLES | 6 0.06 96.64 VENTRICULAR FIBRILLATION | 2 0.02 96.66 VENTRICULAR HYPERKINESIA | 1 0.01 96.67 VENTRICULAR HYPERTROPHY | 6 0.06 96.73 VENTRICULAR HYPOKINESIA | 4 0.04 96.77 VENTRICULAR SEPTAL DEFECT | 4 0.04 96.81 VENTRICULAR TACHYCARDIA | 14 0.14 96.95 VERTIGO | 10 0.10 97.05 VESTIBULAR DISORDER | 3 0.03 97.08 VICTIM OF CHILD ABUSE | 1 0.01 97.09 VICTIM OF CRIME | 1 0.01 97.10 VIITH NERVE PARALYSIS | 1 0.01 97.11 VIRAL INFECTION | 7 0.07 97.18 VIRAL MYOCARDITIS | 1 0.01 97.19 VISION BLURRED | 23 0.23 97.42 VISUAL ACUITY REDUCED | 22 0.22 97.64 VISUAL DISTURBANCE | 10 0.10 97.74 VISUAL FIELD DEFECT | 6 0.06 97.80 VITAMIN D DEFICIENCY | 1 0.01 97.81 VITILIGO | 1 0.01 97.82 VITREOUS DETACHMENT | 1 0.01 97.83 VITREOUS FLOATERS | 3 0.03 97.86 VOCAL CORD DISORDER | 1 0.01 97.87 VOMITING | 94 0.94 98.81 VOMITING PROJECTILE | 1 0.01 98.82 VULVOVAGINAL DISCOMFORT | 1 0.01 98.83 WALKING AID USER | 1 0.01 98.84 WEIGHT DECREASED | 44 0.44 99.28 WEIGHT FLUCTUATION | 1 0.01 99.29 WEIGHT INCREASED | 17 0.17 99.46 WHEEZING | 7 0.07 99.53 WHITE BLOOD CELL COUNT DECREASED | 21 0.21 99.74 WHITE BLOOD CELL COUNT INCREASED | 13 0.13 99.87 WOUND DEBRIDEMENT | 2 0.02 99.89 WOUND DEHISCENCE | 2 0.02 99.91 WOUND HAEMORRHAGE | 2 0.02 99.93 WOUND INFECTION STAPHYLOCOCCAL | 2 0.02 99.95 WRONG DRUG ADMINISTERED | 1 0.01 99.96 WRONG TECHNIQUE IN DRUG USAGE PROCESS | 1 0.01 99.97 XANTHOPSIA | 1 0.01 99.98 XEROSIS | 1 0.01 99.99 YAWNING | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015